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The intervertebral disc (IVD) is a fibrocartilaginous tissue connecting adjacent 
vertebrae in the spinal column. Within the IVD is gelatinous core called the nucleus 
pulposus (NP) which is radially confined by the annulus fibrosus (AF). The AF is 
composed of concentric layers of fibrous lamellae rich in collagen type I and functions to 
support radial forces redistributed from the NP core.15,1 Pathologic conditions of the IVD 
are often associated with low back pain (LBP) which has a lifetime prevalence of up to 
80% and creates an annual economic burden of over $100 billion.2,3 Discogenic pathologies 
associated with LBP include IVD degeneration (IVDD – a multifactorial breakdown of the 
IVD) and/or herniation (IVDH – when IVD tissue is forced beyond or out of the normal 
confines of the IVD).4,35 This results in approximately 2.7 million back surgeries in the 
United States annually.4,5 These surgeries are generally palliative, leaving patients 
susceptible to continued chronic LBP or chance of re-herniation. 
Current methods aimed at repairing the IVD fail to address the focal defect created 
in the AF following discectomy. Furthermore, developing technologies that do effectively 
close AF defects (Intrinsic Barricaid™ and Annulex X-Close™) are made of synthetic 
materials that do not support IVD tissue regeneration.71,74 Therefore, there has been an 
increased focus on using tissue engineering and regenerative therapies to develop an 
effective AF repair system to both restore IVD integrity and mechanics to slow or halt 
underlying degenerative processes. 
Our group has previously developed an outer AF repair patch (AFRP) using sheets 
of decellularized pericardium.122-124 Pericardium contains collagen type I and a fiber 
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orientation similar to native AF tissue. Stacking layers of fiber aligned pericardium 
effectively mimics the angle-ply lamellae of the AF. Despite many promising outcomes of 
the AFRP, it was identified that a biomimetic scaffold was needed that could fill a full-
thickness AF defect, as opposed to only covering the defect in the outer AF. Thus, the goals 
of this research were to i) fabricate a full thickness, multi laminate annulus fibrosus repair 
plug (FT-AFRP) scaffold, ii) determine the scaffold’s ability to mimic the mechanical 
properties of native, full-thickness AF tissue and restore spinal kinematics in a repair 
model, iii) determine the scaffold’s influence on AF cell viability, alignment, and 
morphology. 
The research herein resulted in the development of a repeatable method to fabricate 
FT-AFRPs which effectively mimicked the angle-ply, fiber aligned architecture of native 
AF using decellularized pericardium and an alginate hydrogel casing. FT-AFRPs 
moderately matched compressive mechanical properties of native AF tissue and partially 
restored spinal kinematic parameters in an IVD explant repair model. FT-AFRPs also 
demonstrated cytocompatibility and the ability to support AF cell alignment and 
morphology. Collectively, these results support the potential of the FT-AFRP to be used in 
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1.1 Introduction to Lower Back Pain 
Low back pain (LBP) affects a large majority of the population with a lifetime 
prevalence of up to 80%.6 It is the second highest cause of disability in the United States 
with a 54% increase in years lived with disability from 1990 to 2015.2,7 LBP is the leading 
cause of orthopedic and neurosurgeon visits, and the second most common reason for 
general physician visits.8,9 Patients suffering from LBP experience symptoms ranging from 
persistent dull aches to debilitating sharp pain.10 In addition to an overall reduction in 
quality of life, LBP brings with a significant individual and societal economic burden. Each 
year in the United States, approximately 149 million days of work are lost due to LBP.2 
The associated reduction in productivity and lost wages makes up approximately two-thirds 
of a total annual cost of over $100 billion.2,3   
Figure 1: Median prevalence of lower back pain across sex and age groups.7 
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While the causes of LBP are often multifaceted and difficult to determine, a common 
progression can stem from intervertebral disc (IVD) pathologies. The breakdown of IVDs, 
called intervertebral disc degeneration (IVDD), has been suggested to imply the occurrence 
of both chronic and non-chronic LBP.11 The pathogenic process of IVD degeneration also 
predisposes intervertebral disc herniation (IVDH) in which IVD tissue is forced out of the 
confines of the disc.4 While IVDD and IVDH are two distinctly different challenges, they 
both often result in overall reduction of IVD height, loss of spinal motion, and increased 
pain and debilitation. Overall, these pathologies affect an additional 5% of the population 
in developed countries each year and result in 2.7 million annual back surgeries in the 
United States.4,5  These surgeries, while performed often, are generally palliative, leaving 
patients susceptible to continued chronic LBP or chance of re-herniation. With an aging 
population and recent increasing trends in lumbar degeneration, continued development of 
widespread and effective IVD targeted treatment options are needed to address the 
significant pain and economic burden of LBP.12 
1.2 Intervertebral Disc Physiology 
The vertebral column is made up of individual functional elements called motion 
segments. Each of these segments contains an IVD linking two adjacent vertebrae as seen 
in Figure 2.  
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Figure 2: Overview of IVD location within the spinal column.13 
There are 23 IVDs in the human spine which are classified in three different 
categories: 6 cervical, 12 thoracic, and 5 lumbar. While there are regional differences, the 
main structure of the IVD is common throughout the spine.14 The overall shape of the IVD 
is approximately cylindrical with a slight posterior taper which becomes most prominent 
in the lumbar discs due to the natural curvature of the lower spinal region.14 The IVD acts 
as a shock absorber in the spine, transferring loads throughout the vertebral column while 
maintaining proper mobility and support. To achieve this, the IVD is uniquely designed 
with multiple distinct regions, each interreacting and dynamically contributing to the 
overall functionality of the disc.15 
1.2.1 IVD Anatomy and Function 
The IVD is a fibrocartilaginous tissue with three regions: the nucleus pulposus 
(NP), the annulus fibrosus (AF), and the cartilaginous end plates (CEP).16  
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Figure 3: Overview of the Intervertebral Disc16 
The NP is the central, gel-like core of the IVD largely responsible for distributing 
compressive spinal loads to the AF and CEPs.1 The AF is a multi-layered ring structure, 
wrapping around the NP and confining it concentrically in the disc’s core. The CEPs 
confine the disc vertically and act as the interface between the IVD and associated vertebral 
bodies.17 Altogether, the IVD is the largest avascular tissue in the human body with oxygen 
concentrations dropping as low as 1% in the center of the NP.14 Differences in these tissue 
regions can generally be attributed to the organization and proportion of the three main 
components of the IVD: water, collagen, and proteoglycans. The main collagen types 
throughout the IVD are types I and II.1 The main proteoglycan is aggrecan, a cartilage 
specific proteoglycan.16 The different distributions of these components contribute to the 
swelling pressure, permeability, and compressive properties of the IVD. 
 The NP plays an essential role in the flexibility and stability of the spine. High 
levels of collagen type II and proteoglycans help the NP to remain elastic and resist 
compression under spinal stresses.1 The water content of the NP can be as high as 80%, 
compared to the AF which is approximately 70%.18,19 Other components of the NP 
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structure include elastin as well as rounded chondrocyte like cells.14 The proteoglycans of 
the NP contain a core protein with numerous covalently attached glycosaminoglycans 
(GAGs).20 These carbohydrate chains extend throughout an irregular network of type II 
collagen fibrils.16 The GAGs are sulfated with keratin and chondroitin, giving the NP a 
high charge density. The fixed negative charge causes the influx of counter ions which then 
results in water in-flow. This generates an osmotic swelling pressure, ultimately leading to 
a mix of fluid and solid mechanical behavior. This gelatinous, biphasic mechanical 
response of the NP gives it the ability to support spinal forces and re-direct them to the 
other portions of the IVD.1  
  The AF is composed of 15-25 concentric layers of fibrous lamellae rich in collagen 
type I. Between the layers is a proteoglycan and GAG rich gel interspersed with elastin.14 
The collagen fibers run parallel to each other within each individual layer. The fibers of 
each successive layer run perpendicular to the fibers of the previous layer at angles 
approximately ±30o from the horizontal axis of the IVD as seen in Figure 4.14  Additional 
cross fibers provide further connection between different layers. 
 
Figure 4: Angle-ply architecture of the AF lamellae.21 
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The ability of the AF to bear the forces redistributed by the NP can primarily be 
attributed to this angle-ply structure. While the AF appears as a ring structure, the lamellae 
tend to be discontinuous around the NP core and rather serve as connecting bands between 
adjacent CEPs.22 The architecture and composition are heterogeneous throughout the AF. 
The organization of the lamellae and associated collagen fibers are highly ordered in the 
outer regions of the AF located closest to the edges of the IVD. Towards the center of the 
IVD, within the inner AF, there is a shift to collagen type II as well as an increased level 
of proteoglycans giving rise to a gradual transition from outer AF to the NP.16 Cell type in 
the AF also follows a gradient with similarities to the NP found in the innermost AF 
regions. Elongated fibroblast-like cells are the predominant cell morphology in the outer 
AF. Like the collagen fibers of the matrix, the AF cells are highly organized. The cell 
processes align along the fiber structures of each lamellae, functioning to produce the 
aligned collagenous matrix and further contribute to the mechanical stability of the AF.23 
It has been suggested that cell alignment in this region is initiated by the constant tensile 
forces placed on the AF when the IVD is functioning in physiological conditions.23 Cell 
phenotype shifts to a rounded, chondrocyte-like cell in the inner AF, although both cell 
types are still present. The innermost portion of the AF is often referred to as the transition 
region due to its increased similarity in cell and matrix composition compared to the NP. 
 The CEP is a thin layer of cartilage that acts as an interface between the vertebral 
body and the rest of the IVD. The CEP varies in thickness from 0.1 – 1.6 mm with the 
thinnest regions being above and below the NP.14 While the CEP is primarily referred to 
as being hyaline cartilage, fibrocartilage can also be found in the region surrounding the 
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NP.14,16,24 The primary functions of the CEPs are to act as a mechanical barrier between 
the NP and vertebral bodies as well as for nutrient transport from nearby vasculature.24 
With the avascularity of the IVD as a whole, there is a heavy reliance on nutrient and waste 
exchange to occur through the pores located in the CEPs.25 
1.3 IVD Pathologies and Clinical Significance 
Due to the mechanical interplay between the AF, NP, and CEPs, structural integrity 
of each part is essential to the functionality of the IVD as a whole. Clinically, the two most 
common pathologies are IVD degeneration (IVDD) and IVD herniation (IVDH). The 
progression of IVDD leaves patients susceptible to IVDH. Likewise, damages from IVDH 
can further induce IVDD, leaving a distinct difference but important relationship between 
the two pathologies. 
1.3.1 Degenerative Disc Disease 
 IVDD is the accelerated breakdown of the IVD extracellular matrix (ECM), 
reducing its structural integrity and overall height in the spinal column while showing 
advanced signs of aging.  While IVDD can occur anywhere in the spine, it is most common 
in the lumbar discs (L-1 through L-5), particularly L-4 and L-5.4 Factors contributing to 
IVDD include; physical, environmental, and genetic, leaving underlying processes that 
cause the breakdown difficult to define. The prevalence of IVDD is widespread and can 
occur early in life as IVDs degenerate earlier than other musculoskeletal muscles.26 First 
consistent signs of IVDD have been seen in the age group of 11-16.27 Overall, around 20% 
of teens show mild signs of IVDD.28 In addition to this, most mild cases of IVDD are 
asymptomatic, leaving early detection difficult. The progression of IVDD through older 
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populations is significant with 10% of 50 year old’s and 60% of 70 year old’s showing 
severe signs of degeneration in their discs.26 IVDD has a grading scale with stages 0-4 (4 
being the most severe) as seen in Figure 5.  
 
Figure 5: Progressive stages of intervertebral disc degeneration.29  
IVDD is most distinguishable by a loss of tissue and reduction in the IVD’s 
organizational structure.30 This initial degeneration occurs through mild changes in the 
matrix of the NP and inner AF regions.31 As IVDD progresses, the lamellae of the AF 
become irregular with collagen fibers becoming less organized.26 Additional blood vessels 
are also seen in degenerated discs.32 The overall process begins with  biomolecular damage 
including a loss in proteoglycan and water content.33 The drop in GAG content associated 
with the lowered proteoglycan content reduces the osmotic pressure of the IVD, leading to 
 9 
the loss of hydration.26 These biomolecular changes induce a cellular response including 
cell senescence and apoptosis as well as an irregularity in protein signaling.33 The 
accumulated biomolecular changes of IVDD also lead to phenotype changes of AF and NP 
cells. While little change is seen in overall collagen content in degenerated discs, the types 
and distributions of collagen is altered through IVDD.31 The compromised cellular and 
matrix components of the IVD lead to a negative change in biomechanics through an 
overall loss in hydraulic and viscoelastic properties of the tissue. 
IVDD results in significant changes in the function of the IVD. With a lowered 
osmotic pressure and water content, a degenerated IVD loses height quickly under load.34 
This loss in height under load paired with a fluid flow out of the disc causes the IVD to 
bulge radially. The altered state of the IVD can place irregular stress concentration both 
internally on the AF and CEPs as well as throughout other portions of the spine.26,27,30,31 
When stress concentrations continue to accumulate on progressively degenerated tissue, an 
IVDH can occur. 
1.3.2 Herniation 
 Herniation occurs when IVD material extends beyond the normal boundaries of the 
disc. This extended material can be from the NP, AF, or a combination of both. While 
herniations can occur without pain, as seen by MRI images of herniated discs in 
asymptomatic patients, the pathology can become problematic if nerve compression 
occurs.35 Pinching of the spinal sciatic nerve (sciatica), results in numbness and pain in the 
lower back which can extend into the legs.26,30 Overall, there are four primary 
classifications of IVDH as seen in Figure 6: 1) bulging discs: the AF remains intact but 
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the disc is extended over its normal boundary, 2) Protrusion: NP material pushes into the 
AF region without tearing AF layers, 3) extrusion: NP material is forced through AF layers 
and beyond the outer confines of the disc, 4) sequestration: the NP material extruded 
through the AF is no longer attached to the NP base material.36 
 
Figure 6: Stages of Intervertebral Disc Herniations.36 
IVDH’s occur most commonly posterolaterally where the AF is thinner and where there 
is no accompanying support from adjacent spinal ligaments.37 While it has been thought 
that IVDH occurs purely through mechanical overload of the spine, studies done on healthy 
IVDs have shown that vertebral bodies usually fail before the IVD does under intense 
loading.26 This points towards the predisposition of IVDD for IVDH. 
1.4 Current Treatments of Intervertebral Disc Pathologies 
There are a variety of treatment options for IVD pathologies ranging in 
aggressiveness and effectiveness. As emphasized by the grading severity scales of IVDD 
and IVDH, each pathologic IVD case is unique requiring a different form of treatment. 
Clinically, there are consistent recommendations for evaluating individuals with general 
lower back pain, but a lack of clarity on treatments.30 Many of the available treatment 
options target the symptoms of discogenic lower back pain rather than the underlying 
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pathology of the IVD. The overlying objectives of any treatment option, at the most basic 
level,  should be to alleviate painful symptoms while restoring mechanical function.16 
1.4.1 Non-surgical solutions 
Non-surgical management is often the most conservative treatment option for those 
suffering from LBP, making it a primary option for patients. Options include oral 
analgesics, physical- and psycho- therapy, acupuncture, and steroidal injections.30,36,38 
These treatment options are often appropriate for individuals with milder cases of IVDH 
or IVDD. It has been suggested that non-operative management consist of a multimodal 
approach including anti-inflammatory medication, physical therapy, and education.39 It is 
important to manage the painful symptoms while simultaneously rehabilitating when 
possible. This rehabilitation can be done through specific exercise and manual spinal 
manipulations.40,41 Another recent approach to discogenic back pain consists of 
electrothermal stimulation which has shown to increase function and decrease overall 
pain.42 Long term conclusions are yet to be published on this form of therapy. Continued 
pain, especially caused from sciatica, can lead to the incorporation of corticosteroid 
injections in hopes to reduce nerve irritation and induce healing.  
While these multimodal, non-surgical treatments offer a variety of options, they 
often show limited success. Ongoing and potentially ineffective treatment can become very 
expensive with the average patient spending $3,445 on conservative treatment measures 
before opting for a surgical approach.43 All in all, when a patient’s back pain points towards 
an IVD pathology and becomes a chronic issue after conservative treatment, surgical 
approaches are considered. 
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1.4.2 Surgical Interventions 
 Surgical procedures are often a last resort or an option for individuals with 
confirmed IVD pathologies that cannot be sufficiently treated with conservative measures. 
The main benefit of surgical approaches is that relief of pain can occur faster than non-
surgical options. While pain may subside quicker, the overall advantage for total magnitude 
of pain relief is often smaller for surgical approaches.44,45 Differences in surgical rates 
around the world have raised questions as to the potential over-use of surgical interventions 
in some areas. For example, The US has a rate of back surgery that is five times higher 
than that of the UK.26 Additionally, cases can vary as different surgical approaches are used 
to treat IVDD and IVDH.  
 When IVDD reaches its later stages in a patient, one of two surgical strategies are 
often explored: spinal fusion or total disc replacement (TDR). These currently practiced 
procedures aim to reduce patient’s symptoms rather than to restore the structure and 
function of the IVD. The current gold standard is spinal fusion.46,47 Spinal fusion gained 
popularity in the early 2000’s with a 137% increase in total number of fusion procedures 
between 1998 and 2008.48 This trend has continued in more recent years with a 63% 
increase in lumbar specific fusion procedures between 2004 and 2015, totaling to 199,140 
lumbar surgeries in 2015.49 Spinal fusion consists of removing the damaged IVD and 
creating a bony fusion between the two adjacent vertebrae. Bone graft material is implanted 
where the IVD once was, inducing the bone segments above and below the space to fuse 
together. Metal fixation devices are often implanted to further increase the stability of the 
spine segment while bone is forming. The mobility of the spinal motion segment is 
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removed, but spinal height is maintained in an effort to reduce pain. The overlying problem 
associated with spinal fusion is the accelerated degeneration of adjacent IVDs. Removing 
the shock absorbing capacity of an IVD redirects the forces to adjacent IVDs. It has been 
reported that IVDD in adjacent spinal levels appear as soon as 3 years after fusion 
surgery.50 In addition to the physiological issues, fusion procedures are expensive with an 
average cost of $102,000, further contributing to it being a last-resort option.51 A variety 
of fusion techniques have been developed but little to no difference in success rates has 
been seen in recent studies.52 
With continuing concerns associated with completely removing the spinal motion 
segment through fusion, many have focused on developing a device to completely replace 
the damaged IVD. Like fusion, TDR involves the removal of the damaged IVD. Unlike 
fusion, the implantation of a prosthetic replacement maintains portions of the mobility of 
the native spinal segment. The implant aims to restore harmonic load sharing between 
spinal levels to reduce the occurrence of adjacent segment disease. Implants are typically 
combinations of biocompatible polymers such as ultra-high molecular weight polyethylene 
and metals such as cobalt-chrome molybdenum. There are currently eight TDR devices on 
the market from companies such as Medtronic, Globus, and Zimmer Biomet.53 While TDR 
has been commercially available since the 1980’s, continued investigation is needed to 
confirm the overall success of the procedure. Recent studies have shown improved success 
for TDR compared to spinal fusion with improved patient reported outcomes at both 2 and 
5 year follow ups.54,55 Additionally, a decrease in adjacent level IVDD has also been 
reported.56  While some have reported a reduction in re-operation rates compared to fusion, 
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others have reported no significant difference.55,57 These short-term studies are beginning 
to present significant data to support the use of TDR over spinal fusion, but significant 
challenges for TDR remain. Implant collapse, subsidence, and dislocation can lead to 
severe complications. TDR is also incompatible for a variety of patients such as those with 
high spinal instability or vertebral osteoporosis.53 The largest complication associated with 
TDR is implant wear.58 Wear causes debris deposition which can induce an inflammatory 
response. The response mimics that of a foreign body reaction resulting in bone resorption, 
stimulation of sensory fibers, and the imminent return of pain.59 Recent long-term studies 
confirm that TDR patients suffer a similar deterioration to fusion patients, but at a later 
time. Re-operation rates were as high as 31% for the Charité III lumbar TDR implant after 
a 12 year follow up.60 These studies question the legitimacy of TDR as a successful 
alternative to spinal fusion. Both fusion and TDR are also often overly aggressive 
procedures for those with IVDH.  
 
Figure 7: Spinal Fusion and Total Disc Replacement.61 
One of the most common types of surgery, specifically associated with IVDH, is 
discectomy. This procedure includes making a small incision in the back, exposing the 
IVD, and cutting and removing material protruding from the IVD in order to reduce nerve 
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compression. A laminectomy, where a small portion of the vertebrae is removed, is often 
required in order to reach the site of the herniation.  
 
Figure 8: Discectomy procedure with laminectomy.36 
Up to 300,000 of these procedures occur annually in the United States.62 While 
many patients show positive outcomes following discectomy procedures, recurring issues 
occur for many.  In a recent study examining discectomy success, 7% of cases required 
reoperation by year 1, 9% of cases by year 2, and up to 19% by year 4 with more than half 
due to re-herniations at the same disc level.36,63 Reoccurring herniations are especially 
present in patients who have large protrusions with minimal IVDD elsewhere as well as 
with adolescents with IVDH.62 These conditions are particularly troublesome as removing 
the herniated tissue from the disc requires rupturing the AF, leading to a depressurization 
of the NP. Additionally, disc height is reduced by 25% on average following discectomy 
procedures.64,65 Advances have been made in the procedure, most of which involve 
trending towards a more minimally invasive technique and reducing recovery times. The 
challenge remains as to restoring the structure and function of the AF after discectomy 
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procedures. Long term studies done on discectomy patients showed similar outcomes to 
those opting for conservative treatments.66 Techniques removing different portions of the 
herniated disc also resulted in no significant improvement.67 Overall, the AF fissures 
associate with discectomy as well as the loss of biomechanical stability must be addressed 
in order to further prevent re-herniation and achieve superior clinical outcomes. 
1.5 Repairing the IVD 
 Previously discussed clinical methods to combat IVD pathologies have focused on 
treating symptoms through conservative therapies or palliative surgical techniques. 
Conservative treatments show limited success for patients with higher severity level IVD 
pathologies while surgical options show high levels of implant failure and re-operation. 
For IVDD, Spinal fusion and TDR are generally end-stage procedures that could benefit 
from an earlier stage intervention. Current research is being done to develop an NP material 
to replace degenerated native tissue. Implanting this material would require a pathway to 
the center of the disc, leaving the AF compromised. Likewise, discectomies performed on 




Figure 9: Depiction of the IVDD cascade and subsequent need for AF repair following NP replacement or 
discectomy procedures.68 
 In both cases, a method to replace damaged AF tissue, effectively closing off the IVD to 
re-herniation, would be beneficial. Techniques to address the damaged AF are increasingly 
recognized as an essential development for improved patient outcomes following repair 
procedures. With an additional challenge of slowing down the degenerative process when 
repairing the IVD, a primary focus on tissue engineered scaffolds has emerged.62,69 
1.5.1 AF Closure Techniques 
There have been a variety of attempts at closing the annular defects of the IVD with 
few options currently available. Initial attempts involved simply suturing the AF closed 
with traditional knots. Other techniques involve glues which are primarily composed of 
fibrin or cyanoacrylate. In vitro studies suggested that AF closure with solely suture or glue 
is insufficient but that a combination of both had potential promise.70-72 Cyanoacrylate 
glues, which typically perform better mechanically than fibrin glues, have raised concerns 
of long term cytotoxicity.73,74 Additionally, larger defects pose concerns that are difficult 
to overcome with suture and glue techniques alone. 
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  Recent technologies have built on these findings. The Xclose system (Anulex 
Technologies, Minnetonka, MN) uses tension bands to close the AF.72 One to three tension 
bands are stretched in parallel or cruciate patterns across the AF defect on the outside of 
the IVD. Each band is comprised of a suture loop with tissue anchors at either end. These 
anchors are placed approximately 12mm directly into the adjacent AF tissue. A pre-tied 
knot is used to tighten the bands and secure the anchors, theoretically repairing the AF. 
Despite closing off the outer AF, this technique fails to plug the void throughout the AF, 
leaving NP material to migrate out from the inter region of the IVD. This migration results 
in reduction of disc height and a loss of intradiscal pressure. Additionally, the anchoring 
relies on the structural integrity of AF tissue surrounding the defect. Many other suture-
based products have suffered from similar pitfalls.  
Barricaid™ (Intrinsic Therapeutics, Woburn, MA) is another system that uses a slightly 
different approach. A woven polyester mesh acts as a plug within the annular defect. The 
mesh is attached to a titanium anchor with is implanted into the adjacent endplate.75 The 
incorporation of the mesh blocks material from re-herniating and also aids in maintaining 
disc height. Despite this, the system fails to seal the outer annulus and leaves little potential 
for tissue regeneration or remodeling. Recent follow-up studies have investigated the 
effectiveness of both the Barricaid and Xclose systems in repairing the AF compared to 
discectomies where AFs were left damaged. Studies showed that while these systems do 
reduce the occurrence of re-herniation, no improvements were made in disability and pain 
indexes for patients compared to discectomies performed without AF repair.76 
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Figure 10: Current commercially available AF repair strategies A) Barricaid and B) Xclose system.77 
Current systems focus solely on closing the AF; which they are marginally successful 
at. Pain and disability remain in patients even with reduced rates of re-herniation. This 
issue is most likely linked to both the migration of material in an IVD as well as the 
continued degenerative process after repair. Overall, a system is needed that 1) closes the 
outer AF defect, 2) keeps NP material in the center of the disc by filling AF defect space, 
3) has potential to regenerate and remodel the damaged IVD tissue to slow the degenerative 
process. Mechanically, this system would need the best aspects of both the previously 
mentioned products: replacement material throughout the thickness of the AF as well as an 
outer seal. Combining these aspects would pair lowered rates of re-herniation with 
improved patient outcomes through maintained disc height and restored mechanical 
stability. The achievement of restored function paired with slowing the degenerative 
process further points towards the development of a biomimetic, tissue engineered system.  
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Currently, research is being done to develop a biomimetic scaffold for outer AF closure 
that is implanted onto the outside of the disc after discectomy or nuclear arthroplasty as 
seen in Figure 11.  
 
Figure 11: An annulus fibrosus repair patch (AFRP) intended for outer AF closure. 
While such a system may prevent NP material from leaving the confines of the disc, it 
does not keep the NP in the center of the IVD where it possesses the most mechanical 
functionality. This problem constitutes the need for a scaffold that occupies the entire full 
thickness of the AF defect, aiding in the retention of the NP as well as the overall restoration 
of mechanical stability in the IVD.  
1.6 Tissue Engineering the Annulus Fibrosus 
With the challenge of both preventing re-herniation as well as promoting healing 
and/or slowing the degenerative process, tissue engineering and regenerative medicine 
have moved to the forefront of research. The breakdown of the IVD is attributed to cellular 
and biomolecular changes. These changes lead to a change in tissue morphology, and 
ultimately, lost biomechanical performance. Considering this, the overlying aspect of 
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IVDD is matrix structure. This structure is dependent on the balance of cell metabolism 
within the IVD in order for proper maintenance of the matrix.78 Overall, while a 
mechanically competent replacement is needed to aid in closing the AF, the cellular aspect 
is equally as important in achieving total clinical success through a slowed degenerative 
process. This is the aspect that many commercially available AF closure techniques fail to 
address. 
Gene and protein therapies have opened a potential option to stimulate matrix and 
aid in repairing the IVD. These strategies have been administered through techniques such 
as direct injection into degenerated discs. Despite this, the progressive nature of IVDD has 
garnered suggestions for continued therapeutic administration for sustained 
stimulation.79,80 One leading option constitutes the incorporation of cell therapies with a 
mechanically competent scaffold. Achieving this requires a biomimetic scaffold that 
follows the structure of native AF tissue in order to provide correct cellular stimulus for 
the repaired IVD. In addition to cellular signaling, similar matrix structure between an 
engineered and native AF could also provide similar mechanical properties, ultimately 
leading to corrected mechanical function of a repaired IVD. In order to best create this 
scaffold, it is important to understand the native AF structure and healing capacity as well 
as previous attempts at engineering AF scaffolds. 
1.6.1 Native AF Healing Capacity 
 The intrinsic healing potential of the IVD is generally considered poor.62 Low mean 
cell counts in the IVD of 6000 cells/mm3 paired with an avascular and biomechanically 
demanding environment make natural regeneration a significant challenge.81 This is 
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supported clinically by the progressive and high prevalence of degeneration. Despite this, 
minor repair processes have been observed in the AF.81 The healing capacity that is present 
is potentially connected to the chemotactic mechanisms of chemokines. Chemokine 
receptors have been identified on human AF cells.62 The ability of chemokines to recruit 
AF cells has also been confirmed.82 Whether the process is chemotactic or not, low but 
continuous proliferation rates have been shown in different parts of the IVD including the 
AF.83 Furthermore, stem cell niches around the border of the IVD have been reported and 
there is evidence that these cells migrate into the AF to work with local progenitor cells 
towards tissue regeneration.83 Increasing evidence of mesenchymal stem cell (MSC)-like 
progenitor cells have been reported in AF, NP, and CEPs of both healthy and degenerated 
human IVDs.84-86 The overall function of these repair mechanisms may be disturbed by the 
inflammatory and catabolic processes associated with degeneration and IVD damage.87 
Overall, this leads to an insufficient natural healing process, especially when damage has 
been initiated through events such as IVDH and discectomy. 
Smith et al. suggested that the healing process of the AF occurs in three different 
phases.88 First, a proliferative reaction in the fibrous tissue induces healing of the outer AF. 
This process begins at the outermost portions and works towards the median portions of 
the wound. Secondly, the healing process continues to the inner AF in a similar manner to 
the healing of the outer region in the first phase. This process begins within a few weeks 
and lasts up to a year post-operation. Lastly, collagenous fiber density begins to increase 
in the NP material that protruded into and remained in the AF wound after injury. This 
ultimately leads to a fibrous and stiffer structure than healthy tissue. 
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The healing process of the AF has been investigated further in many different 
animal studies.88-95 Key and Ford used a dog model with different induced posterior 
annulus lesions.89 The lesion groups included a transverse incision, puncture with a 20-
gauge needle, and an open square annulus window. The lesions were initially found to fill 
with blood, fibrin, bone, and cartilage debris. This was slowly replaced by a thin layer of 
fibrous tissue over the course of 22 weeks. Some lesions developed disc protrusion, which 
was most common in the transverse incision group but also seen in the annulus window 
group. The needle puncture group showed no abnormalities and the lesions could not be 
identified after 22 weeks. This finding was challenged by a more recent study through an 
organ culture model with rabbit IVDs.96 This study concluded a progressive mechanical 
and biologic consequence from needle puncture in longer term follow-ups. 
 From these various studies it is evident that a healing process occurs in the AF 
following injury, but that it is very limited in regenerating the IVD to a healthy and 
functional state. Various theories have been proposed for this limited healing potential, but 
much remains unknown. One potential reason for clinical insufficiencies is that the exterior 
AF repairs associated with intrinsic healing do not adequately recruit fibers to the tensile 
forces demanded by the IVD. Mechanical shifting of axial load in the NP to circumferential 
tension in the AF requires keeping NP tissue volume elastic and contained. Scarred tissue 
changes the AF’s ability to contain the NP, ultimately leading to accelerated herniation and 




1.6.3 Regenerative Medicine and Cell Therapies 
 The value of cells to the metabolic health of the IVD prompts the strategy of 
replacing, regenerating, or augmenting the native cell population under pathologic 
conditions. This would work towards the goal of correcting matrix deficiencies to aid in 
the restoration of proper biomechanics in the IVD.62 A variety of techniques have been 
tried to achieve this goal. One approach is to stimulate disc cells to produce more matrix 
through the introduction of growth factors.97 In contrast, cytokine inhibitors have also been 
tried in order to prevent the breakdown of matrix.98 The direct injection of these factors has 
shown little success due to their inability to maintain effectiveness over extended periods 
of time. Cell implantation is another approach to directly address the scarcity of healthy 
cells in damaged AF tissue. The incorporation of analogous or autologous cells has shown 
success for other applications such as articular cartilage and has therefore been applied to 
IVD repair. The implantation of autologous cells in small populations of patients has shown 
success but long term outcomes need further investigation.78 The ability for these cells to 
live in the damaged AF long term remains a challenge. Similar to the injection of growth 
factors, cell implantation has limited long term success when proper nutrient supply and 
scaffold conditions are not present as with many IVDH and IVDD cases. Other than low 
chance of survival, challenges for cell implantation include cell leakage out of the intended 
injury site, unwanted osteophyte formation, and general difficulty of implantation into the 
IVD.99,100 Cell sources are also a potential issue which will be addressed in subsequent 
sections. 
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 When cells are successfully implanted and viable, it has been shown that they 
respond to matrix and mechanical stimulation, ultimately contributing to a modulation of 
inflammation and promotion of repair.101 These implanted cells repopulate regions of the 
AF where native cells and  extracellular matrix (ECM) have been lost through a deposition 
of matrix proteins. This is supported by studies showing that cultured AF cells retain 
proliferative capacity, demonstrate an ability to generate correct matrix, and undertake 
expression consistent with the phenotypic demands of IVD anatomy.78 Obtaining AF cells 
requires direct implantation of the correct cell type or the implantation of stem cells that 
have the potential to differentiate into the correct cell type. Therefore, it is essential to 
provide a scaffold that AF or stem cells can live on in order to achieve their benefits 
surrounding regeneration. 
1.6.4 AF Cell Sources 
 One of the major issues limiting the use of biological AF repair is a suitable cell 
source.102 Often, the first consideration in identifying a cell source is if cells should be 
autologous, allogenic, or xenogeneic. Another consideration is the way in which the cells 
are cultured once isolated as certain conditions can aid in proper integration with tissue 
once implanted. Cells can also be harvested from a tissue type that is different than the one 
intended to be repaired. Lastly, stem cells can be considered with their potential to 
differentiate into desired cell types. Overall, there are many options for cell sources, each 
with their own advantages and limitations. These items to be considered for cell therapy 
must therefore also be considered when choosing a cell source to supplement a tissue 
engineered scaffold. 
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 Using the Intervertebral disc as a source of autologous cells is an obvious first 
approach, but one which possesses significant limitations. Low cell counts and regional 
phenotypic changes make isolating a significant number of the correct cells difficult. 
Additionally, taking a biopsy punch of tissue to extract cells inevitably means puncturing 
the AF. With the heathiest cells coming from the least degenerated discs, this would mean 
potentially inducing IVDD and eventual IVDH to repair an IVD at a different spinal level. 
Another issue associated with human adult AF cells is that the majority of them are reported 
to be dead or dying through necrosis or apoptosis.27 Senescence is another common 
occurrence associated with adult AF cells which unfavorably alters cell metabolism and 
growth.103 The same concerns apply to allogenic or xenogeneic AF cells with additional 
challenges of disease transmission and immune responses. Despite these challenges, 
autologous AF cell therapy has been incorporated clinically with discectomy procedures. 
A European study of 112 patients compared outcomes for patients undergoing discectomy 
procedures with and without subsequent autologous AF cell treatment.78 The study 
reported moderate success of AF cell treatment to preserve disc structure. Reported 
limitations of the study included potential inclusion of inflammatory cells as well as the 
requirement of a second procedure for cell implantation. Overall, the use of AF cells shows 
promise, but there is a significant challenge in obtaining them autologously in a healthy 
state without inducing damage to the transplant site.  
 With the challenges associated with obtaining heathy AF cells, focus has shifted 
towards the use of stem cells for regenerative therapy.62 As with AF cells, autologous cells 
pose the least clinical hurdles in terms of patient compatibility. A popular choice is 
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mesenchymal stem cells (MSCs) which can be obtained autologously from various 
locations including bone marrow, adipose tissue, muscle and dermis, umbilical blood, and 
others.104 MSCs are known to be able to differentiate into many different cell types 
associated with bone, cartilage, adipose tissue, and muscle.102 The ability of MSCs to 
differentiate into disc like phenotypes is still under investigation. Studies have reported 
that MSCs can adopt a gene expression profile similar to native disc cells.103 Co-culturing 
MSCs with disc cells has also shown a sped up process of discogenic phenotype expression 
but these studies have focused on the chondrocyte like phenotype of NP cells.105 MSCs aid 
in the repair process of the IVD in a few different ways, including: 1) by differentiation 
into disc-specific cells to replace lost or damaged cells and to form new ECM, 2) indirectly, 
through the release of growth factors to enhance regeneration, 3) by modulating the 
inflammatory response.104 
 
Figure 12: Major sources of stem cells used for IVD engineering.100  
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One of the main limitations of MSCs is that many patients with back pain are 
middle-aged, giving their stem-cells little expansion potential. To limit this challenge, a 
potential allogenic source could be younger donors. Another option for allogenic or 
potentially autologous stem cells is from umbilical tissue. This is a continuously more 
achievable source as tissue banks are established. An additional challenge is for MSCs to 
repair the IVD in a useful amount of time. Studies done on MSC’s production of GAG and 
aggrecan, two important molecules lost through IVDD, have suggested that stem cell 
injection by itself is not enough to restore the disc.106 From a clinical standpoint, trials done 
with stem cells have shown varying success. The injection of undifferentiated 
hematopoietic stem cells into patient’s IVDs showed no clinical success.105 A more recent 
study using bone marrow concentrate cells did show pain reduction.107 Companies have 
continued entering the market for clinical trials on cell-based therapies in recent years. 
Studies done have supported that a variety of cell sources, homologous and non-
homologous, autologous and allogenic, can retard the degenerative process of the IVD 
following IVDH.108 The challenge remains of having a viable cell source and scaffolding 
for cellular support.   
1.6.5 Scaffolds Under Development 
 An ideal biomaterial for AF repair would provide instant and prolonged mechanical 
stability and allow new healthy tissue to form.62 It has been suggested that a biocompatible 
scaffold that mimics the angle-ply architecture of the native AF would be the holy-grail for 
AF repair.109 Many scaffolds are currently being developed with several overlying focuses 
as described in Table 1. Many different strategies have been used to engineer such a 
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scaffold with materials ranging from injectable hydrogels, to decellularized extracellular 
matrix, to synthetic polymers. 
Table 1: Overlying goals for AF repair scaffolds from Bowles et al. and Cruz et al.101,109 
General Goals and Qualities of AF Repair Scaffolds 
Restoration of mechanical function of the damaged or diseased AF. 
Prepared scaffold architecture that supports AF or other relevant cell types. 
Ability to delivers biologics to promote ECM production and tissue formation. 
Allow easy translation to current surgical procedures. 
Seal irregular shaped AF defects to prevent re-herniation and cell leakage. 
Restore IVD height and mechanical behavior. 
Withstand prolonged exposure to the mechanically demanding environment of the IVD. 
 
 Due to the high levels of collagen in native AF, cell scaffolds have been developed 
using injectable collagen-based gels.110-112 Different combinations of collagen type I and II 
have been used to mimic the collagen content in the inner and outer regions of native AF. 
Advantages of collagen based scaffolds include a weak immunogenicity and the ability to 
support a variety of cell types.62 These gels have been supplemented with fibrin as well as 
GAGs such as chondroitin sulfate or hyaluronan, which are natively seen within the AF.  
In 2018, Moriguchi et al. published a paper on the use of high density collagen gels 
seeded with AF cells as a repair strategy in an in vivo rat model.111 These gels consisted of 
collagen type I extracted from rat tail tendons which was digested and diluted to 20 mg/mL. 
The collagen solution was gelled with a 0.75 mM solution of riboflavin and mixed with 
ovine AF cells before implantation into rat tail defects. This study concluded that the high-
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density collagen gel improved disc height, NP size, and disc hydration after 5 weeks when 
seeded with AF cells. Demonstration of durability and NP retention was shown, but little 
was done to legitimize the gels ability to restore mechanical function.  
In 2014, Guterl et al. proposed an optimized fibrin gel for AF repair (FibGen).113 
The initial fibrin gel was enhanced through genipen crosslinking as well as the addition of 
cell adhesion molecules, fibronectin, and collagen. In vitro tests demonstrated durability 
and mechanical tunability through slowed degradation rates compared to fibrin only gels 
as well as shear stiffness values similar to native AF. Culturing AF cells in FibGen gel 
resulted in an elongated morphology. This could potentially be advantageous when seeking 
the fibroblast like cell type associated with native AF tissue. While the FibGen gel shows 
promise for very small annular defects, it is incapable of sealing larger defects without 
accompanying scaffolds. Additionally, further studies by this group demonstrated that the 
material is cytotoxic when cells are incorporated into the gel before gelation occurs. 
Analogous gels have been developed using other natural hydrogels such as agarose, 
alginate, and chitosan.114,115 Altogether, the gels discussed have widely shown 
advantageous cellular support as well as easy implantability. What these materials lack is 
a robust mechanical strength comparable to native AF tissue as well as a fiber aligned 
architecture. Thus, focus has shifted towards developing scaffolds that better mimic the 
mechanical properties and organization of the native AF.62  
One natural material that has been identified to have both advantageous mechanical 
properties as well as a high affinity for cell attachment is silk.62 Various processing 
techniques also give the potential to create a silk scaffold that mimics native architecture. 
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In 2007, Chang et al. studied the ability of AF cells to attach to and grow on porous silk 
scaffolds supplemented with RGD peptides.116 It was concluded that AF cells attach to silk 
scaffolds, proliferate, and synthesize ECM. In addition, the inclusion of RDG peptides 
showed changes in cell morphology that could aid in replicating cell type differences 
between inner and outer AF regions. In 2018, Bhunia et al reported that these silk scaffolds 
were able to be processed into a mimetic angle-ply construct.117 Lamellar sheets were 
fabricated using a directional freezing method. Aligning multiple layers together resulted 
in an angle-ply structure with compressive properties similar to native AF. While these 
scaffolds show promise, they are primarily used as part of a whole IVD replacement. The 
silk sheets are intended to wrap completely around an NP replacement core rather than to 
close an annular defect. Further research may be needed to develop a suitable closure 
technique using this material. 
Various synthetic materials have also been used to create a full thickness scaffold 
with a focus on polymeric biomaterials. Polymeric biomaterials have been used in many 
other tissue engineering applications due to their lack of immunogenicity, predictable 
mechanical properties, reproducibility, and ease of processing into desirable structures.62 
Popular biodegradable polymers for AF tissue engineering are polycaprolactone (PCL), 
Polylactic acid (PLA), and polyglycolic acid (PGA). Various techniques of processing 
these polymers have included freeze-drying, salt-leaching, weaving, thermal phase 
separation, and electrospinning. The most often used method to produce porous structure 
for AF repair is electrospinning.62 It has been shown that depositing electrospun nanofibers 
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onto a rotating mandrel can dictate both fiber alignment as well as mechanical anisotropy 
needed to mimic native AF.118  
 
Figure 13: Scanning electron microscopy images of non-oriented (A) and oriented (B) electrospun PCL.62 
In 2007 Nerurker et al. detailed the electrospinning of PCL to produce AF-like 
tissue.118 Their processing technique resulted in singular sheets of aligned fibers. Although 
these sheets are not a full thickness annular repair, they are the base units needed to develop 
a full annular closure scaffold. Uniaxial tensile testing on the sheets resulted in the most 
similar results to native AF lamellae when fibers were oriented between 28o-44o, 
demonstrating the mechanical mimicry of the material. In addition, seeded AF cells aligned 
along the fiber structure and deposited matrix when scaffolds were placed under 
physiological loads. Further developments for this scaffold have focused on developing a 
whole disc replacement with agarose as a central NP replacement.119 Other labs with 
electrospun PCL and PLA scaffolds have yielded similar results mechanically and 
cellularly.120  
In 2017, Kang et al. used similar electrospinning techniques as previously described 
but fabricated cylindrically shaped scaffolds with multiple layers of fiber-oriented lamellae 
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of PCL.121 These cylinders were formed by thermally fusing 13 individual lamellae and 
punching out both 4- and 6-mm diameters with a biopsy punch. Scaffolds were seeded with 
porcine bone marrow derived MSCs and used to repair induced annular defects in an in-
vivo porcine model. The repair consisted of the PCL scaffold to plug the defect, a 
cyanoacrylate closure glue, and an outer suture closure method. Follow up studies at 6 and 
12 weeks concluded that repairs successfully restored nucleus volume and slowed the 
degenerative process as observed trough MRI imaging. Aligned collagen was also 
observed integrating with the PCL plug at 12 weeks. Further studies are needed to 
determine the integration and mechanical outcomes as the PCL scaffolds degrade. 
Insufficient integration upon complete degradation of the scaffold would result in the return 
of pain and herniation potential.  
Other synthetic, full thickness annular plugs have been developed using 
stereolithography (SLA) techniques. Blanquer et al. used poly(trimethylene carbonate) 
(PTMC) processed with SLA to achieve a gyroid-porous structure as seen in Figure 14.122 
 
Figure 14: A) Cylindrical poly(trimethylene carbonate) AF repair scaffolds and B) scanning electron microscopy 
image of porous scaffold structure.122 
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 Repair studies were done with PTMC scaffolds in a bovine injury model.112 Bovine 
caudal spinal segments (vertebrae-IVD-vertebrae) were extracted and injuries were 
induced by a 5 mm biopsy punch. Repairs consisted of implantation of the cylindrical 
PTMC scaffold, injection of FibGen gel, and closure of the defect with a combination of a 
polyurethane membrane, fibrin adhesive, and suturing. The motion segments were put 
through a complex loading regimen and kinematic parameters of the repaired motion 
segments were compared to uninjured control groups. The repairs partially restored IVD 
biomechanics but posed a high risk for re-herniation.  
Overall, there have been many different attempts at creating a scaffold to both 
replace the damaged AF as well as to act as a carrier for regenerative cells. Natural gels 
show abundant cell support and implantability but lack adequate closure and mechanical 
functionality. Silk and electrospun polymers can correctly mimic angle-ply architecture 
and support cell life but have widely been used as part of a whole intervertebral disc 
replacement. Plug shaped synthetic scaffolds show mechanical and cellular promise but 
have yet to be studied long term as they degrade. The overall important findings throughout 
studies outlined that AF scaffolds must 1) mimic the mechanically anisotropic quality of 
native AF, 2) support relevant cell types ultimately leading to scaffold integration with 
native tissue, and 3) be used in conjunction with supporting techniques to achieve complete 
AF closure. 
1.7 Towards A Tissue Engineered, Full-Thickness AF Repair Scaffold 
 LBP is a widespread clinical problem that can often be traced to IVD pathologies 
such as IVDD and IVDH. In the case of IVDH, the AF is inevitably damaged through the 
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initial herniation process or subsequent discectomy repair procedures. There are currently 
few commercially available options to repair the damaged AF, resulting in high rates of re-
herniation and continued LBP. Repair strategies that do exist are able to prevent re-
herniation, but do not play any role in modulating the continued degenerative process. 
Regenerative medicine approaches and tissue engineered scaffolds have been developed in 
hopes to combine solutions to the mechanical and cellular aspects of discogenic LBP, but 
none have shown all-around success. While some scaffolds under development have shown 
either mechanical or cellular advantages, few have shown both. Those scaffolds that do 
satisfy both needs are made of synthetic materials that do not provide additional ECM for 
re-integration. Others are simply unsuitable for an AF point defect and instead are focused 
towards whole IVD engineering. 
 The research herein aims to build off the most successful aspects of previously 
developed commercial products and scaffolds currently under development to step closer 
to an all-encompassing AF repair strategy. The intended strategy will fill the void of 
annular defects to prevent herniation and restore overall IVD mechanics. The strategy will 
also allow for the delivery of gene- or cell-based therapies to manage the onset of IVDD. 
Lastly, the strategy will include a scaffold that is biomimetic to provide proper cellular 
cues as well as add additional ECM to re-incorporate with intact native AF tissue. 
Investigating such a strategy will include developing a scaffold fabrication method, 
studying the mechanical mimicry of the scaffold compared to native AF tissue, and 







2.1 Introduction and Purpose 
Previous efforts have identified decellularized porcine pericardium as a potential 
material for AF repair scaffolds.123-125 Pericardium is comprised of both dense regular and 
irregular connective tissue. Most of this connective tissue is type I collagen which is 
organized in directional fibers as seen in native AF tissue.123 Multiple sheets of pericardium 
were overlaid such that the fiber preferred directions mimicked the fiber structure of AF 
tissue. Specifically, three layers of pericardium were adhered together via a sewing 
machine and ultimately used as a patch to close the outside of annular defects.  This resulted 
in a mechanical response similar to AF tissue as well as a partially restored kinematic 
response when used to repair an injury model.124 Additionally, the decellularization of the 
pericardium resulted in a cytocompatibility that supported cell viability, penetration, and 
proliferation.   
 
Figure 15: A) Decellularized pericardium and B) a 3-layer angle-ply AF repair patch (AFRP). 
A B 
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While major advances were made in developing the AF repair patch (AFRP), the 
scaffold is only intended to close the outside of an annular defect. The AFRP does not 
replace AF tissue throughout the disc resulting in a failure to keep NP material in the center 
of the IVD.  
 
Figure 16: Schematic depicting outer AF closure of an IVD defect using the AFRP as well as the needed 
full-thickness AF scaffold. 
Thus, the objective of this aim was to fabricate a full thickness, multi-laminate annulus 
fibrosus repair plug scaffold (FT-AFRP). The FT-AFRP was developed beginning with 
fabrication techniques of the AFRP, involving multiple layers of decellularized porcine 
pericardium. The FT-AFRP scaffold was intended to work in conjunction with the AFRP 
as a total AF replacement strategy. The studies performed herein include the trials in 
extending the AFRP into a full thickness plug, refining the scaffold to a proper size and 
fiber orientation, adhering layers of pericardium together, the potential inclusion of a GAG 
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gel between plug layers, developing a repeatable process to manufacture the plugs, and the 
potential to freeze dry the fabricated scaffolds. Outcome measurements were primarily 
qualitative involving repeatability and consistency in fabrication methods of the FT-AFRP. 
Quantitative measurements included size comparisons to potential AF defect sizes. 
2.2 Materials and Methods 
2.2.1 Specimen Procurement, Dissection, and Treatment 
 Porcine hearts were obtained within 4 hours of slaughter from a local abattoir. All 
tissue was put on ice upon procurement. The parietal layer of pericardium was separated 
from the rest of the heart. Excess fat and connective tissue was manually removed from the 
pericardium using tweezers and scalpel. The parietal layer of pericardium is fused and 
inseparable from the fibrous layer which is the outermost layer of the pericardium. The 
dense, regular connective tissue associated with the fibrous layer of pericardium is 
comprised of collagen fibers running in parallel directions to one-another. The subsequent 
decellularization of the pericardium was adapted from methods described by Tedder et al 
and modified by McGuire and Borem et al.123,126 Before fabricating scaffolds, pericardium 
was crosslinked using 6 mM 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride (EDC), 1.2 mM N-hydroxysuccinimide (NHS), 50 mM MES buffer 
solution. Sheets of pericardium were clamped together and submerged in the crosslinker 
solution overnight (12 hours). 
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Figure 17: Layers of pericardium.127 
2.2.2 Initial Strategies for FT-AFRP Fabrication  
 Initial attempts at fabricating the FT-AFRP were developed from previous methods 
of AFRP fabrication. The fabrication of AFRPs included placing single layers of 
pericardium on a light box to identify fiber orientation. Layers were stacked on top of each 
other at ± 30o to re-create the native angle-ply fiber configuration. Stacked layers were then 
placed on a water-soluble backing material (solvy-ultra) and sewn together with a sewing 
machine in squares with dimensions of 8 x 8 mm2. Patches were then stored in ddH2O for 
4 hours to ensure complete dissolution of backing material. Three-layer patches had a 
thickness of 0.8 mm. Each subsequent approach described aims to move further towards a 
full thickness, angle-ply annulus fibrosus repair scaffold. 
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Figure 18: Angle-ply layer structure of three layer AFRP.123 
Fabrication Approach 1 
To begin to extend the multi-layer patch into a full thickness scaffold, trials of stacking 
6 layers of pericardium together were done to determine if an increased layer count could 
be sewn together successfully. The patch dimensions were also increased for this trial to 
approximately 2 x 2 cm2. Subsequent trials of sewing together 6 layers of pericardium 
involved partially drying the tissue by dabbing with a Kimtech wipe before stacking as 
well as replacing needle and foot components of the sewing machine. Another approach 
was to initially sew two separate 3-layer patches and then to sew together the two different 
3-layer patches. 
Fabrication Approach 2 
Next, 8-layer patches were fabricated with an extended length, resulting in dimensions 
of 9 mm x 4.5 mm. These patches were fabricated using the same method as the 3-layer 
AFRPs. The patches were folded in half, perpendicular to the long axis, to increase total 
scaffold thickness to 16 layers while maintaining the fiber-oriented architecture. To secure 
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the patches in their folded orientation, a simple interrupted knot was tied into each the four 
corners using a 3-0 suture. It was ensured that knots tied into the two corners on the folded 
side of the patch did not wrap around the rounded edge. This was done to allow the folded 
edge to be cut with a scalpel once all four corners were secured. Doing this opened the 
folded-up end and exposed all 16 layers like the other three sides of the patch. 
Fabrication Approach 3 
 In order to obtain a cylindrically shaped plug, the use of a biopsy punch in the 
fabrication method was trialed. Initially, a reusable metal 6mm biopsy punch was used. 
This punch was determined to have too large a wall thickness and an insufficient sharpness. 
Disposable 6mm biopsy punches were used. 6 mm was the chosen size for the punch due 
to the classification of AF defect sizes switching from the category of large to small at 6 
mm in diameter.128 Four 6-layer patches with dimensions 2 x 2 cm2 were fabricated using 
the sewing method described previously. The tissue was marked to note the fiber alignment 
direction within each patch. The four patches were stacked. The 24 layers of pericardium 
were punched through with the 6 mm disposable biopsy punch. The stacked plug of 
pericardium was removed from the biopsy punch using tweezers. Punches of 12 layers of 
pericardium were also taken and compared for overall height. Height measurements were 
taken with a ruler. 
Fabrication Approach 4 
 In order to better hold pericardium layers in place while punching, layers of 
pericardium were stacked onto a needle system. A U-100 insulin needle tip was taped to 
the lab bench in an upright position. A cutting surface was placed over the needle with a 
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hole cut out for proper needle clearance. 24 layers of pericardium were individually stacked 
onto the needle. With the needle inserted through the layers, a plug was punched out using 
a biopsy punch. Both 6- and 8-mm diameter plugs were fabricated.  
 
Figure 19: Needle guided AF plug fabrication showing A) needle set-up, B) stacked pericardium layers, and C) 
plug and excess pericardium after biopsy punching. 
2.2.3 Adhering Pericardium Layers 
  Various techniques were tried to keep the individual layers of pericardium together 
once punched. These techniques included suturing, a hyaluronic acid (HA) hydrogel, a 
commercial grade wound sealant, and an alginate gel. The approaches described could be 
applied to any the scaffold formation approaches described in the previous section. The 
main goal in adhering layers was to maintain integrity of the layers during implantation. 
Adhering Approach 1 
 Hyaluronic acid (HA)-gel was prepared by reconstituting 1% sodium hyaluronate 
in PBS. Preliminary attempts to asses the ability of the HA hydrogel to adhere pericardium 
layers was done by injecting the HA gel between layers of 2 x 2 cm2 3-layer patches. 
Patches were clamped shut and submerged in 6mM EDC, 1.2 mM NHS, 50 mM MES 
crosslinker solution overnight. Qualitative assessments of layer adherence were conducted.  
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Additional studies were done to directly incorporate the HA hydrogel into the AF repair 
plug fabrication method. 24-layer stacks of 6 mm diameter punched pericardium were 
placed into the caps of centrifuge tubes. The diameter of the centrifuge tube cap was 8 mm. 
HA gel was pipetted into the centrifuge tube to surround the AF scaffold. The centrifuge 
tube was closed, turned upside down, and the bottom was cut off to create an opening to 
pipette in crosslinker solution. Scaffolds remained in crosslinker solution overnight. Once 
the HA gel was solidified, scaffolds were removed from the centrifuge tube caps with 
forceps and qualitatively assessed for adherence and durability. The plug was squeezed 
vertically and laterally, and layers were attempted to be pulled apart. 
 The procedure was repeated with the use of a commercial grade sealant instead of 
the HA hydrogel. Tisseel (Baxter Int. Deerfield, IL), a fibrin sealant often used for wound 
closure was used. The provided injection kit was used to surround AF plugs with sealant 
in centrifuge tube caps. The sealant was allowed to solidify for 30 minutes before removing 
scaffolds from centrifuge tube caps and assessing. 
Adhering Approach 2 
 A dip coating method was developed to encase the stacked layers of pericardium in 
an alginate gel. A 2.4% alginic acid sodium salt solution was created. 24-layer plugs were 
punched using a 6 mm biopsy punch and excess pericardium was removed. The plugs were 
picked up with forceps, dipped in the alginate solution, and slowly removed to ensure an 
even coating around the plug. A 102 mM CaCl2 co-factor solution was used to crosslink 
the alginate into a solidified state. The alginate coated plugs were dropped into the co-
factor solution and left for 10 minutes. Plugs were removed and qualitatively analyzed for 
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alginate coverage, adherence, and durability. Additional trials were done in which plugs 
were dipped in co-factor solution first and then dropped into the alginate solution. 
 Adhering Approach 3 
 24 layers of pericardium were stacked without the use of a fixation needle. A 4-0 
braided suture with a curved diamond point needle was used to pierce through all layers of 
the pericardium. Suture thread was pulled through the layer of pericardium and a simple 
stop knot was tied to anchor into the bottom layer of pericardium. The thread was 
subsequently fed through a disposable biopsy punch to ensure the suture was not cut when 
punching out the pericardium layers. The 6 mm biopsy punch was used to punch through 
the 24 layers of pericardium. The punched layers were removed from the excess tissue and 
the suture was unfed from the biopsy punch.  
 In alignment with the development of stacking pericardium on a needle, further 
suture-based trials were done with a 4-0 straight needle suture. The 60 mm straight needle 
was positioned like the insulin needle previously described. 24 layers of pericardium were 
stacked and punched with a 6 mm biopsy punch. The needle and connected suture were 
pulled through the pericardium plug. A stop knot was tied at the end of the suture. The 
suture line was cut so to leave approximately 5 cm of additional suture on the side opposite 
the stop knot. 
Combinational Approach 
 With multiple approaches having certain desirable qualities of a repeatable and 
consistent fabrication method, a combinational approach was taken. 24 layers of 
pericardium were stacked onto a straight needle with suture attached. A plug was punched 
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out with a 6 mm biopsy punch and removed from the excess pericardium. A stop knot was 
tied on the bottom side of the plug and 5 cm of excess suture was left on the stop side of 
the plug. The excess suture was used to dip the plug in alginate solution without handing 
the scaffold with forceps. The alginate encased plugs were then crosslinking in the co-
factor solution previously described for 10 minutes. Suture was removed from the plugs by 
pulling the stop knot out away from the scaffold with forceps. 
2.2.4 Plug Fabrication Jig Design 
 To create a repeatable and consistent method of FT-AFRP fabrication, a 3-D printed 
base was created. The base was designed to hold multiple needles in an upright position as 
well as to aid in securing the pericardium in place while punching. SolidWorks (Dassault 
Systèmes, Vélizy-Villacoublay, France) computer aided design software was used for 
drawing models. The system included a base and a clamping plate as seen in Figure 20. 
The base designed had a 35 x 35 mm2 platform to house the suture needles and mount the 
pericardium. The clamping plate was designed to fit around the mounted pericardium and 
platform to provide additional support while biopsy punching the pericardium scaffolds. 
The SolidWorks part files were used to 3-D print the system with nylon PA12 fiber. 
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Figure 20: Engineering drawings with dimensions in mm of the A) base and B) clamp plate as well as C) a 3-D 





 To fabricate plugs using the 3-D printed system, four straight needle sutures were 
first fed through the holes in the base platform. The base was secured to the benchtop using 
spring clamps. Pericardium layers were cut into squares 40 x 40 mm2 as to be slightly larger 
than the mounting platform. A single layer of pericardium was separated. The fiber 
direction of the pericardium layer was identified by holding up the tissue to a light source. 
The layer was gently stretched, manually aligned to the center of the mounting platform, 
and pushed downward to puncture with all four needles. Once down to the base platform, 
curved forceps were used to flatten out any wrinkles in the individual layer of pericardium.  
 
Figure 21: Steps of the final plug fabrication process using the 3-D printed base including A) stacking 
pericardium layers, B) punching plugs and removing excess tissue, and C) removing needles from base and 
sliding plugs down onto suture thread. 
This process was repeated for each subsequent layer of pericardium until the 
desired height or layer number was achieved. The 3-D printed clamp plate was then placed 
over the pericardium and gently pressed down onto the base to wedge the layers of 
pericardium against the sides of the mounting platform of the base. A 6 mm biopsy punch 
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was used to punch through all layers of the pericardium. Once all four plugs were punched, 
the clamp plate and excess pericardium were removed from the system. The straight 
needles, with stacked pericardium plugs attached, were pulled through the top of the base 
plate. Plugs were pushed off the needles and onto the suture using forceps. The 
combinational technique previously described was then applied to secure the plug to the 
suture and to coat the plug in alginate gel.  
2.2.5 Freeze Drying and Rehydration of AF Plugs 
 Additional studies were done to assess the ability of FT-AFRPs to be freeze dried. 
The ability of scaffolds to be dried and rehydrated could play an important factor in storage 
and transportation. While only assessed qualitatively, the ability of FT-AFRPs to return to 
their pre-dried state after rehydration was under investigation. After fabrication, FT-AFRPs 
were frozen at -80o C and transferred to a freeze-drying system. A FreeZone 6 Plus 
(LABCONCO, Kansas City, MO) freeze dryer was used to expose the plugs to a 0.1 mBar 
and -88o C atmosphere for 12 hours. Plugs were removed from the freeze dryer and 
qualitatively assessed for structure. A rehydration assessment was done to investigate the 
freeze-dried FT-AFRP’s ability to reabsorb liquid and return to their previous state. Freeze-
dried FT-AFRPs were placed in conical tubes and 1.5 mL of 1x Phosphate buffered saline 
(PBS) solution was added. The FT-AFRPs were left to rehydrate for 24 hours. After 
rehydration, FT-AFRPs were removed from PBS solution and the pericardium and alginate 





2.3.1 Specimen Procurement, Dissection, and Treatment 
 Our group has previously confirmed the decellularization of porcine pericardium 
through agarose gel electrophoresis, immunohistochemistry, and Nanodrop DNA 
analysis.123 These studies demonstrated the complete removal of alpha-Gal, a porcine 
antigenic epitope, and a DNA content of 96.2 ± 13.4 ng/mg of dry weight tissue; a 95.3% 
decrease as compared to fresh porcine pericardium.123 Additionally, the crosslinking 
treatment of pericardium was found to significantly lower mass loss from collagenase 
digestion while not significantly altering tensile properties.124 
2.3.2 Strategies for AF Repair Plug Fabrication  
 Initial attempts at sewing together 6 layers of pericardium in a similar method to 
AFRP production was initially unsuccessful. With an increased layer count, pericardium 
slid out from its flat orientation when attempting to sew. Replacing the needle of the sewing 
machine and partially drying the pericardium gave improved outcomes. Ultimately, 6- and 
8-layer patches were able to be manufactured with practice. The technique of folding 
patches resulted in a 16-layer thick square with sutures at all four corners. The height of 16 
layers was approximately 3.1 mm. The scaffold was essentially an extension of the AFRP 
with a square shape.  
Biopsy punched plugs, without the use of a needle support, produced cylindrical 
but irregularly shaped plugs as seen in Figure 22. 12-and 24 layer plugs measured 3.2 ± 
0.1 and 5.8 ± 0.2 tall respectively. The diameter measurements varied slightly due to the 
inconsistency in layer alignment throughout the plug. 
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Figure 22: A) 12 and B) 24 stacked layers of pericardium punched with 6 mm biopsy punch. 
 The insulin needle system used to hold pericardium layers together while punching 
resulted in more uniformly aligned plugs as seen in Figure 23. Plugs punched with 6- and 
8-mm biopsy punches measured consistent diameters equivalent to punch diameter. Height 
measurements average 4.6 ± 0.3 mm across all 6 and 8 mm diameter plugs. 
 
Figure 23: A) top and B) side views of 6- and 8-mm diameter plugs fabricated with insulin needle support. 
2.3.3 Adhering Pericardium Layers 
 The injection of HA gel between enlarged 3-layer patches was unsuccessful through 
multiple trials. The patches were found to have little to no gel between layers upon removal 
from crosslinking solution. No adherence was felt between layers upon manual shearing of 
the layers. Direct incorporation of HA gel around punched AF repair plugs showed better 
A B 
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but still little overall promise. The gel was not able to be properly crosslinked into a rigid 
coating through the procedure described. Gel that did crosslink on the top of the scaffold 
was not able to aid in the overall adhering process of the scaffold. Using the commercial 
grade fibrin sealant, Tisseel, showed better adhering outcomes. The application of the 
sealant resulted in a non-uniform but rigid layer surrounding the plug as seen in Figure 17. 
The sealant was not able to properly coat the bottom of the plug that was on the bottom of 
the centrifuge tube. Portions of the sealant also migrated between the layers causing them 
to split. Sticking to the centrifuge tube also resulted in difficulty of removing the plugs 
from the cap. Diameter and height measurements averaged 7.0 ± 0.1 and 6.3 ± 0.3 mm 
respectively, indicating an approximate 0.5 mm thick layer of sealant around the outside 
of the plug. 
 
Figure 24: A 24-layer AF repair plug A) before removal from centrifuge tube, B) from a side profile, and C) 
with inconsistent sealant coverage.  
 The dip coating method used with the alginate gel resulted in consistent and 
complete coverage of AF repair plugs, successfully holding all layers together. 
Inconsistencies in the alginate coating resulted partial blockage of the areas being directly 
held by the forceps. A slightly rounded top was also consistent throughout plugs on both 
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the tops and bottoms. Average diameter and height for 24-layer plugs were 6.0 ± 0.2 mm 
and 5.5 ± 0.1 mm respectively. 
 The use of suture was able to hold together layers of pericardium. Overall, 
consistency was more achievable when a straight needle suture was used. Overall heights 
of 24 layer plugs were smaller than other fabrication methods at 4.2 ± 0.2 mm. A knot was 
not able to be tied tightly onto the top side of the plug. 
 The combinational approach of using needle, suture, and an alginate dip coating 
resulted in the most consistent and robust plugs. A complete alginate coating around all 
edges of the plug was seen. The alginate encased the plug in a slight oval-like shape with 
the edges of the plug being relatively flat but the tops and bottoms being rounded. The 
average height and diameter for these 24-layer plugs was 6.3 ± 0.4 and 7.0 ± 0.1 mm 
respectively. The largest inconsistencies were seen in the shape and overall height of the 
rounded edges of alginate on the plugs. 
 
Figure 25: 24-layer plugs fabricated with straight needle, suture, and an alginate dip coat with A) suture 
removed and B) suture left in the scaffold. 
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2.3.4 Plug Fabrication Jig Design 
 The 3-D printed scaffold properly housed the straight needle sutures during 
fabrication. Additionally, the clamping plate successfully aided in the proper alignment 
and tension of the pericardium while biopsy punching. The needles and attached suture 
were easily fed through the base upon completion of plug punching. The resulting plugs 
were produced in consistent batches of four and were comparable to the plugs using the 
combinational approach previously described.  
 
Figure 26: A 30-layer AF repair plug fabricated using the 3-D printed base (left) compared to a 6-mm punch of 
native bovine AF tissue (right).  
2.3.5 Freeze Drying and Rehydration of AF Plugs 
 The alginate coating appeared to remain intact when plugs were freeze dried. Upon 
rehydration, plugs regained their original shape with a slight decrease in size. The alginate 
coating did return and was comparable to its original shape. For samples in which the 
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alginate coating did not completely surround the plug, individual layers of pericardium 
flaked off after freeze drying.  
 
Figure 27: Freeze drying study showing A) top view of a dried plug, B) a 30-layer re-hydrated plug, and C) 
individual layers of pericardium falling off plug. 
 
2.4 Discussion 
2.4.1 AF Repair Plug Fabrication 
 The concept of the FT-AFRP was based off previous studies done on the AFRP for 
outer AF closure. Thus, extending the AFRP method of fabrication was an obvious starting 
point to increase the layer count of the scaffold to achieve a full annular thickness. Sewing 
of an increased number of layers generally did not work due to slipping of pericardium 
layers while sewing. That being said, a consistent method of creating 6-layer, large-sized 
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patches was useful in advancing the overall fabrication technique. Layers of pericardium 
were sewn into 6-layer squares for the crosslinking process as well as for more efficient 
stacking for subsequent fabrication techniques. The process of folding over patches and 
suturing corners was not sufficient as it resulted in square scaffolds and could not be 
applied for high layer counts of 24. While AF defects can often be irregularly shaped, a 
cylindrical shape is most applicable to a range of potential defects. Additionally, defects 
could potentially be shaped or punched to proper size also constituting a cylindrical 
scaffold. The biopsy punch easily cut through pericardium layers and gave the required 
cylindrical shape. Continued issues of layer slippage required a mechanical holder of 
pericardium layers which was implemented in the form of an insulin needle.  
 Once cylindrical plugs of up to 30 pericardium layers were able to be fabricated 
consistently, a method to adhere layers together was still needed. While native AF tissue 
is made up of individual lamellae, they have an innate adherence to each other through 
overlapping collagen matrix and an interlamellar GAG gel.14 Previous investigation of the 
incorporation of a GAG gel between layers AFRPs resulted in improved mechanical 
properties, specifically, impact resistance.125  While the incorporation of an HA gel was an 
attractive strategy due to its re-incorporation of GAGs and potential to adhere layers, the 
methods used to implement the gel were insufficient. While the use of a GAG gel is 
certainly a future need for the AF repair plug, the HA gel was not robust enough, even if 
applied successfully, to hold the plug together. Future research will be conducted to 
incorporate GAG between layers of the plug, but the gel was not be able to serve as the 
main adherence method.  
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 The commercial grade sealant, Tisseel, provided a stronger outer layer for the plug. 
Tisseel is primarily used for wound closure and therefore posses the correct mechanical 
strength to properly hold the AF repair plug together. Additionally, it has been shown to 
be biocompatible and has been used for other tissue engineering applications.129 While the 
application kit allowed for easy injection of the sealant around the plug, only small amounts 
were obtainable at a time. The method of injecting into a centrifuge tube cap was 
insufficient in producing a consistent outer layer around the plug, even when a high-quality 
sealant was used like Tisseel. With the identified need for a dip coating method paired with 
expense concerns over fibrin sealant, alginate was identified as an alternative. 
 Alginate was a readily available alternative that had increased durability compared 
to HA gel and which could also be obtained in much higher quantities than Tisseel. 
Alginate hydrogels are commonly used in tissue engineering applications due to their 
ability to support cell life and tunable mechanical properties.130 3-D alginate scaffolds have 
also produced more relevant gene expression profiles when AF cells are cultured in them 
as compared to monolayer culturing.131 These characteristics made alginate an attractive 
and potentially dynamic outer adhering sealant. The proper amount of alginate gel to allow 
for dip coating was also easily produced. This technique resulted in the most consistent 
plugs, especially when the combinational technique which included the straight needle 
suture was used. The gel casing on the outside of the plug was only intended to hold layers 
together well enough for potential handling and implantation. This was achieved by the 
alginate gel.  Mechanical and cellular contributions of the alginate to the overall scaffold 
characteristics was yet to be determined. 
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 The sizing of the AF repair plug was generally targeted to be 6 mm in diameter and 
24 layers thick. The diameter was based off AF defect size characterization categories. The 
height of plugs was not specified to an exact requirement as sizes could vary. General 
thickness of human lumbar AF is 5-6 mm.68 All fabrication techniques needed to be tunable 
to different biopsy punch sizes as well as a variety of total layer numbers. This was 
achievable by the combination fabrication technique previously described. 
2.4.2 Plug Fabrication Jig Design 
 Streamlining the fabrication process was important as nearly every initial attempt 
at making FT-AFRPs resulted in a different geometry and overall quality. The 3-D printed 
base achieved the consistency needed. The ability to make four plugs out of each batch of 
stacked pericardium greatly improved overall consistency. It also reduced the time needed 
to create plugs. While initial designs intended to use two clamping plates to hold together 
all layers of pericardium at once, it was found that stacking layers directly onto the needles 
one at a time was much easier. One potential issue with the technique was the danger 
associated with manually forcing biopsy punches directly towards suture needles that were 
sticking up out of the base. Despite this, future manufacturing implications for scalability 
could easily be achieved with machine automation of a similar but larger scale process.  
2.4.3 Freeze Drying and Rehydration of AF plugs 
 The ability to freeze dry resulting scaffolds was inconclusive. Qualitatively, plugs 
that were initially fabricated with a complete alginate coating were able to maintain their 
structural integrity upon freeze drying and rehydration. This could be an important long-
term factor for packaging and shipping implant materials. A common problem was that 
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plugs did not dry as complete scaffolds, but rather as individual pericardium layers 
resulting in the flaking reported previously. The continued improvement in consistency 
and overall alginate coverage could potentially improve freeze drying capability as well. 
2.4.4 FT-AFRP Development: Key Takeaways 
 The research in this section produced a repeatable method to fabricate a full 
thickness AF scaffold using sheets of fiber-aligned decellularized pericardium, an alginate 
hydrogel, and a 3-D printed jig. While FT-AFRPs contained a similar ECM and fiber 
alignment compared to native AF, it was still undetermined whether that translated into 
appropriate mechanical and cellular behavior. Subsequent sections focus on the 







3.1 Introduction and Purpose 
 Human lumbar IVDs undergo complex compressive loading during activities of 
daily living. Axial compressive spinal loads imparted on lumbar IVDs generate intradiscal 
pressures (IDPs) ranging from 0.1-2.3 MPa.132 These IDPs can fluctuate based on body 
position and can abruptly increase through activities such as lifting heavy objects, jumping, 
and valsalva maneuvers. These IDPs are redirected by the NP into radial and 
circumferential tensile forces on the AF. When abrupt increases in IDPs occur in 
degenerate IVD, herniations can occur. The damage done to the AF directly through IVDH 
or subsequently through discectomy or NP replacement procedures requires a viable 
method of AF repair. This repair must aid in restoring the mechanical interplay between 
the NP and AF by properly responding to forces redirected from IDPs imparted by the NP. 
To achieve this, many have focused on creating void filling biomaterials to replace missing 
AF tissue throughout the full thickness (5-6 mm) of the AF. These scaffolds have widely 
shown the ability to support cell life but have produced varying results in terms of 
mechanical mimicry of native AF tissue. Additionally, focus has been placed on 
developing an outer AF closure device to prevent re-herniation that works in conjunction 
with full thickness AF scaffolds towards AF repair. Thus, our lab has developed both an 
outer closure (AFRP) and full thickness (FT-AFRP) scaffold using fiber aligned sheets of 
decellularized porcine pericardium. The FT-AFRP is the most recent addition to an IVD 
repair system involving the AFRP as well as a previously developed NP replacement 
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(ABNP) material. The research herein aims to determine the FT-AFRP’s ability to mimic 
the mechanical properties of native AF tissue and restore spinal kinematics in an IVD repair 
model. 
 To compare the FT-AFRP to native AF tissue, confined compression was chosen 
due to useful outcome parameters such as hydraulic permeability and aggregate 
compressive modulus as well as well documented data of healthy and degenerated AF 
tissue. Studies have shown that radially punched samples of human AF tissue possess 
hydraulic permeability and aggregate compressive modulus values of 2.1 – 5.0 ×10-16 m4/N 
s and  0.40 – 2.5 MPa respectively.133 
 While mechanical mimicry of the AF repair plug is an important indicator in 
replicating native AF tissue, the ultimate requirement is the ability to restore overall disc 
mechanical function. Previous studies have been done using the AFRP and ABNP in a 
spinal repair model.125 These studies concluded that the repair system only partially 
restored spinal kinematics. It was concluded that the repair did prevent re-herniation in the 
spinal model but that many kinematics parameters may have remain altered due to the 
migration of NP replacement material into the AF defect region. These studies not only 
justify the need for a full thickness AF repair scaffold but also warrant follow up studies to 
identify the FT-AFRP’s ability to restore spinal kinematics. 
3.2 Materials and Methods 
3.2.1 Analysis of  FT-AFRPs in Confined Compression 
FT-AFRPs were fabricated using decellularized sheets of porcine pericardium. 
Pericardium was crosslinked as previously described. Test frame and confining chamber 
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setup required plug dimensions of 5 mm in diameter and 1 – 3 mm in height. FT-AFRPs 
were fabricated through 12 individual layers of fiber aligned pericardium, a 5 mm biopsy 
punch, and a dip coating of alginate. The slightly rounded edges on the tops and bottoms 
of the 12-layer plugs were sheared to be flat using a microtome blade. All samples were 
maintained in a PBS storage solution containing protease inhibitor at 4℃ for up to 3 weeks 
before testing.  
 Testing was done in conjunction with Dr. Yongren Wu (Medical University of 
South Carolina) via Martin Groke. This testing was done on a DMA Q800 test frame (TA 
Instruments, New Castle, DE) equipped with a 5mm diameter confining chamber, 5 mm 
diameter impounder, and a porous bottom platen (Figure 28D). Each FT-AFRP (n=6) was 
loaded into the confining chamber and loaded to an average preload of 0.064 N for height 
determination. A PBS solution was added to the chamber and samples were then subjected 
to a strain of 3% of total sample height. Samples equilibrated for 30 minutes at the 3% 
strain and final static force measured was used as the creep test pre-load force. Samples 
then underwent a 1-hour creep period in which a ramp force of 120% of the pre-load force 
was applied and held. Time and strain data was exported to Origin Pro software and fit to 
a biphasic model modified by Kuo et al. to determine dimensionless variables p and K 
(Figure 28C).134 Aggregate modulus (HA) and permeability (k) values were then calculated 
using the following equations: 𝑝𝑝 = 𝑃𝑃0
𝐻𝐻𝐴𝐴






Figure 28: Study design for confined compression of FT-AFRP samples. Images depicting A) confining chamber 
setup, B) stress and strain representations of creep tests, C) biphasic model used to determine aggregate 
modulus and permeability values, D) DMA Q800 test frame setup. 134 
Statistical analysis was performed on permeability and aggregate modulus values of 
FT-AFRPs using Microsoft Excel software. Values were compared to human AF sample 
values using an unpaired two-tail t-test. Results are represented as mean ± standard error 
of the mean (SEM). Significance was defined as (p≤0.05).  
3.2.2 Biomechanical Evaluation of IVD Repair Model Axial Kinematics 
FT-AFRPs were fabricated using decellularized sheets of porcine pericardium. 
Pericardium was crosslinked as previously described. Plugs were fabricated through 24 
individual layers of fiber aligned pericardium, a 6 mm biopsy punch, and a dip coating of 
alginate. 3-layer multi-laminate AFRPs were also fabricated from decellularized 
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pericardium. Compacted and crosslinked NP replacement material (ABNP) was fabricated 
using a previously developed method.135 All samples were maintained in a PBS storage 
solution containing protease inhibitor at 4℃ for up to 2 week before testing.  
Bovine caudal tails were obtained from a local grocer, Publix (Clemson, SC). 
Functional spinal units (FSUs: vertebrae-IVD-vertebrae) were harvested from the top 
caudal level (cc1-2) of each tail. Excess tissue and ligaments were removed from the 
vertebral bodies and IVDs via dissection. With posterior elements attached, the vertebral 
bodies of each FSU were cut to a flat and even edge using a band saw. The FSUs were 
potted using 3mm steel rods and urethane potting resin. The steel rods were intended to 
further prevent slippage of FSUs out of the potting material during testing. The IVDs of 
potted FSUs were wrapped with gauze saturated with PBS, stored in zip-lock bags, and 
frozen at -80℃. Prior to testing, FSUs were thawed in zip-lock storage bags by submerging 
in water at ambient temperature for four hours. 
FSUs (n=6/group) underwent kinematic testing according to methods previously 
described by our group with slight modifications.124 FSUs were tested in the following 
groups: uninjured, injured, repair using a native bovine AF plug, and repair using the FT-
AFRP (Figure 29A). To produce an injury, a 6mm biopsy punch was used to remove AF 
tissue. NP material was then removed through the AF perforation with forceps and a 
scalpel. Repairs were done by physically compacting ABNP to remove excess fluid, 
implanting ABNP until the center region of the IVD was filled, implanting either the 
previously punched out native AF or FT-AFRP, and closure of the annular defect using an 
AFRP. Attachment of the AFRP consisted of suturing at all four corners and all four edges 
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of the square patch using 4-0 FiberWire suture. Before each group was tested, FSUs were 
allowed to equilibrate in PBS solution with protease inhibitor at 4℃ for twelve hours. FSUs 
were repaired prior to swelling for the two repair groups. Testing order for the two different 
repairs was randomized for each FSU to avoid testing order bias. Wet and dry weights of 
all removed and implanted material were taken and compared. Dry weights were taken by 
freeze drying samples before massing. 
Testing was done on a Bose ElectroForce model 3220 (TA Instruments) equipped with 
a 100-lb. load cell and test chamber filled with 1xPBS and protease inhibitor at ambient 
temperature. Samples were loaded to a mean amplitude level of -0.125 MPa before 
undergoing a 1-hour creep period at -0.50 MPA (Figure 29C). Samples were then returned 
to the -0.125 MPa amplitude level before undergoing 35 cycles of axial compression and 
tension at amplitude levels of -0.50 MPa and 0.25 MPa respectively at 0.1 Hz. Samples 
finally underwent a slow-rate compressive ramp at 1 N/s from the -0.125 mean amplitude 
level to -0.50 MPa (Figure 29B). Tensile and compressive stiffness was determined using 
a linear fit of the loading force-displacement curve from 60-100% of peak stress the 35th 
cycle. Axial range of motion was determined from the total peak-to-peak displacement of 
the IVD in the 35th cycle. The constant-rate slow-ramp compression stiffness was 
determined using a linear fit of the load displacement response. A custom MATLAB code 
was written to properly extract the 35th cycle and determine all previously described 
parameters. The program was also used to graph the 35th cycle and slow ramp curves with 
colors coordinating to the 60-100% loading regions (Figure 29D). A second MATLAB 
code was written to determine creep and step displacement values from creep data. The 
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step displacement was defined as the IVD displacement when loading from -0.125 MPa to 
-0.50 MPa. Creep displacement was defined as the displacement of the IVD during the 1-











𝜂𝜂2 � was fit to creep data using GraphPad Prism 7 software. This fit determined 
elastic (Ψ) and viscous (η) damping coefficients for the short term (η1 and Ψ1) and long-
term (η2 and Ψ2) response of the IVD. 
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Figure 29: Study design for in situ kinematic testing of bovine IVD FSUs using annulus fibrosus repair plugs. A) 
Representative images of the testing progress of each FSU (the order of repair 1 and repair 2 was randomized). 
B) Loading scheme for FSU testing depicting creep loading, axial cyclic tension compression loading, and 
constant-rate slow ramp loading. C) Representative graph of creep loading and displacement parameters. D) 
Representative image of a 35th tension-compression cycle isolated using MATLAB code with red and blue lines 
depicting the region of 60-100% of peak amplitude.68 
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Statistical analysis was performed on raw data using GraphPad Prism 7 software. 
Results are represented as mean ± standard error of the mean (SEM). Significance was 
defined as (p≤0.05). Tissue weights were evaluated using a paired t-test. Kinematic data 
were evaluated using a one-way repeated measures ANOVA. 
3.3 Results 
3.3.1 Analysis of AF Repair Scaffold and Human AF in Confined Compression 
 FT-AFRP samples measured an average height of 2.10 ± 0.21 mm. Aggregate 
modulus and permeability values for FT-AFRP samples averaged 141.52 ± 17.59 kPa and 
756.28 ± 219.51 ×10-16 m4/N s, respectively. These values differed significantly from 
human AF samples as seen in Figure 30. 
 
Figure 30: Results of FT-AFRP in confined compression and compared to human AF values for A) aggregate 




3.3.2 Biomechanical Evaluation of Functional Spinal Unit Axial Kinematics 
 An average of 109.67 ± 1.14 mg dry weight of tissue was removed from each IVD 
for the injury group. This included both NP and AF tissue. Average total material re-
implanted for repair with native and repair with FT-AFRP were 85.10 ± 1.26 and 69.33 ± 
0.62 mg dry weight respectively (Figure 31). While amount of material re-implanted was 
significantly lower than removed material for both repair groups, there was no significant 
difference between the two repair groups. 
 
Figure 31: Average amounts of removed and re-implanted material. Solid lines connecting groups indicates 
significant different (p<0.05). 
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Axial cyclic kinematic testing of FSUs with a discectomy defect significantly 
altered compressive stiffness, slow-ramp compressive stiffness, tensile stiffness, and axial 
range of motion values compared to uninjured controls. Repair with either the native plug 
or AF repair plug further altered tensile stiffness (Native AF: 130.25 ± 3.80, Repair Plug: 
131.84 ± 7.31 N/mm) and axial range of motion values (Native AF: 4.20 ± 0.24, Repair 
Plug: 4.22 ± 0.22 mm) compared to uninjured control and injury groups (Figure 32C&D). 
While still significantly altered, native AF and repair plug values began to return to control 
values for compressive stiffness (Native AF: 626.97 ± 34.75, Repair Plug: 609.16 ± 36.62 
N/mm) and slow-ramp compressive stiffness (Native AF: 431.62 ± 17.14, Repair Plug: 
419.40 ± 16.04 N/mm)(Figure 32A&B). There were no significant differences seen 
between repair with native AF and the repair plug. 
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Figure 32: Axial cyclic tension compression kinematic testing results of bovine IVD FSUs. Graphs of A) 
compressive stiffness, B) slow-ramp compressive stiffness, C) tensile stiffness, D) axial range of motion. Solid 
lines connecting groups indicates significant different (p<0.05). 
Creep loading of FSUs with a discectomy injury did not significantly alter step 
displacement or short-term viscous, long-term elastic, or long-term viscous damping 
coefficients compared to the uninjured control group (Figure 33B&D-F). Parameters were 
significantly altered through injury and remained altered after either repair group for creep 
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displacement and short-term elastic damping coefficient compared to the control group 
(Figure 33A&C). While not initially altered through injury, the short-term viscous 
damping coefficient for FT-AFRP repair was not significantly different from the control 
group while Native AF repair was significantly different (Native AF: 4170.50 ± 
595.41N/mm, p=0.026, FT-AFRP: 5422.17 ± 835.32 N/mm, p=0.376) (Figure 33D). 
Although still significantly altered compared to uninjured controls, FT-AFRP repair was 
closer to maintaining or restoring parameters to control levels than native AF repair for 
step displacement (Native AF: 0.52 ± 0.03 mm, p=0.003, FT-AFRP: 0.46 ± 0.03 mm, 
p=0.047) and short-term elastic damping coefficient (Native AF: 308.41 ± 21.00 mm, 
p=0.003, FT-AFRP: 332.87 ± 18.88 N/mm, p=0.010) (Figure 33B&C). 
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Figure 33: Creep kinematic testing results of bovine IVD FSUs. Graphs of A) creep displacement, B) step 
displacement, C) short-term elastic damaging coefficient, D) short-term viscous damaging coefficient, E) long-
term elastic damaging coefficient, E) long-term viscous damaging coefficient. Solid lines connecting groups 
indicates significant different (p<0.05). 
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3.4 Discussion 
3.4.1 Confined Compression 
 The annulus fibrosus is made up of 15-25 fiber-aligned concentric lamellae rich in 
collagen type I. These fibers play a crucial role in the strength of healthy AF tissue to 
support the hoop stresses brought on from NP force distribution. The FT-AFRP was 
constructed to mimic the ECM components and fiber orientation of native AF. Therefore, 
it is essential to understand the ability of the FT-AFRP to also mimic the mechanical 
properties of native AF tissue. The confined compression studies herein demonstrated that 
the FT-AFRP and native human AF tissue have significantly different but comparable 
aggregate moduli and a severely different permeability. While the fiber orientation of the 
AF may play an important role in tensile properties, the replication of the alignment with 
the FT-AFRP may not be enough to completely replicate compressive properties of native 
tissue. While the collagen content and fiber alignment are similar between pericardium and 
native AF lamellae, there are various components missing from the FT-AFRP that could 
also contribute to compressive properties. The lamellae in native AF are connected by 
collagen cross-fibers as well as a GAG- and elastin-rich gel. Thus, the inclusion of an 
adhering GAG gel between layers could further improve similarities. The GAG gel 
between layers may play an even more important role in correcting the permeability values 
of FT-AFRPs.  
 The permeability of the AF contributes to the ability of fluid to flow through the 
tissue, ultimately dictating its mechanical response. The mechanical behavior of the IVD 
is often described as a product of the biphasic properties of each of its tissue components; 
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that is, the elastic, permeability, and swelling properties of the AF and NP.136 Measuring 
the associated biphasic parameters is an important benchmark in tissue engineering to 
better model the AFs mechanical behavior and fluid transport. The higher permeability 
value associated with the FT-AFRP compared to human AF may be advantageous for 
increased nutrient transport throughout the generally avascular tissue but could ultimately 
affect the mechanical response negatively. Lowering the permeability value further could 
be achieved and potentially fine-tuned by the previously mentioned GAG gel. Additionally, 
cell seeding and subsequent tissue remodeling could play a role in the mechanical 
properties of the FT-AFRP. 
While the permeability and aggregate modulus values of the FT-AFRP failed to 
replicate that of native tissue in this study, other reported values in the literature have varied 
significantly as seen in Table 2. The FT-AFRPs aggregate modulus falls within the range 
of values reported in the literature, but its permeability value was not. Studies using 
confined compression and the biphasic model have widely been accepted as sufficient in 
modeling the AF, but procedural differences produce significantly different results.136 
Despite this, the results herein are compared to human AF tested under the same conditions 









Table 2: Reported biphasic parameters of native AF tissue from various groups as reported by Cortes et al.136 
Parameter Native AF Value 













 The main function of the IVD is to allow for adequate stability and flexibility in the 
spine. This is achieved through a dynamic interplay between healthy AF and NP tissue 
contributing to normal spinal kinematics. One key kinematic parameter used to define 
spinal motion is total range of motion of the spinal segment. Normal values for range of 
motion for healthy lumbar spine segments in flexion, extension, and lateral bending are 
7.6º, 3.8º, and 6.6º respectively.137 These values change under pathologic discogenic 
conditions like IVDD and IVDH.138 An additional consideration for overall IVD function 
is the ability to bear load. Human Lumbar IVDs can experience axial compressive loads of 
up to 1200N during daily activity and up to 2350 N during overly strenuous activities.139 
Therefore, it is essential to understand the ability of the FT-AFRP to contribute to restoring 
normal spinal segment kinematics under similar conditions.  
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The FT-AFRP showed little success in restoring parameters such as tensile 
stiffness, compressive stiffness and range of motion in a bovine FSU repair model. Range 
of motion values continued to increase, even after implantation of repair materials, 
potentially pointing towards tissue fatigue after multiple sample runs. The same can 
potentially be said about tensile stiffness values which are unlikely to be restored without 
complete integration between implanted repair scaffolds and surrounding native tissue. A 
method to directly re-incorporate the FT-AFRP with native tissue may aid in reversing 
these altered parameters. Compressive stiffness values remained significantly altered after 
repair with both native AF and FT-AFRPs but began to rise back up to control values. 
Compressive forces imparted on the IVD are primarily borne by the NP and secondly 
supported by the AF. While the altered compressive stiffness parameters could be caused 
by an inadequate NP replacement material, an equally important aspect is the ability of the 
FT-AFRP to keep NP replacement in the center of the IVD. Removal of tissue after testing 
revealed that NP material still migrated into the AF region even with an AF replacement. 
This further points to the need for mechanical integration of the FT-AFRP with surrounding 
tissue to provide a more sufficient annular seal, and ultimately, further improved 
compressive, tensile, and range of motion properties. Furthermore, an average of 
approximately 70% of dry weight of material removed from injury groups was re-
implanted in repair groups. While this number is higher than what has been previously seen 
by our group and could be caused by density differences, a more efficient packing method 
could result in more material contributing to IDP restoration and ultimately restored 
parameters. 
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 Creep response of the IVD is generally associated with the NP in the short-term 
and with the AF in the long-term.140 This was partially supported by the study herein. Both 
long- and short-term model parameters were altered through induced injury but a limited 
ability to restore these altered parameters was seen for either repair group. The short-term 
viscous damping coefficient was not altered through injury or FT-AFRP repair but did 
show significant differences with native AF repair. Additionally, the short-term elastic 
damping coefficient remained altered but was closer to uninjured control values with the 
FT-AFRP repair compared to native AF repair. This illustrates that the FT-AFRP is aiding 
in keeping NP material in the center of the disc better than the native AF plug replacement, 
allowing the NP to more properly dictate the short-term response. Despite this, significant 
changes in long-term coefficients remained following repair with either scaffold. The hoop 
stresses associated with the load bearing of healthy AF tissue may be the missing 
component in the void filling FT-AFRP. Even if proper retention of NP material to the 
center of the disc were achieved, long-term kinematic parameters would potentially remain 
altered unless the proper tension was restored throughout the AF through re-integration 
with adjacent tissue. Our group is currently working on a suture technique to secure AF 
repair tissue to adjacent native tissue. 
Different patterns in parameter restoration were seen between this study and 
previous kinematic studies done by our group. These discrepancies may be due to the 
inclusion of a swelling period between each testing group. Allowing IVD tissue to re-swell 
could change the defect volume, shape, and subsequent repair. Additionally, studies herein 
were adapted from previous procedures from our group but optimized to be run entirely on 
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one test frame. This also could have contributed to differences between this and previous 
kinematic repair studies using bovine FSUs. Overall, with few significant differences 
between native AF plug and FT-AFRP repairs, it can be said that the FT-AFRP scaffold 
itself can mimic native AF tissue in a repair model, but that a space filling AF scaffold may 






4.1 Introduction and Purpose 
 The need for regenerative strategies has been identified for IVD, and more 
specifically, AF repair due to a low intrinsic healing capacity. Regenerative strategies aid 
in slowing the degenerative process of the IVD and are often achieved through cell and 
gene-based therapies. Cell based therapies have shown moderate clinical success but need 
a competent scaffold to support long term proliferation and promote proper differentiation 
in the case of stem cell implantation.62 Additionally, it has been shown that implanted cells 
alone do not have the ability to produce adequate amounts of GAG and aggrecan needed 
to restore AF tissue.106 These limitations warrant a scaffold that supports cell life and 
differentiation but also mimics native tissue for mechanical restoration and potential long-
term integration with surrounding tissue. The need for a cell-based therapy and a competent 
scaffold warrants the investigation of how the two items interact.  
 Native cells of the outer AF are elongated and fibroblast-like. Inner AF regions 
transition to a mixed cell morphology with an increased amount of rounded, chondrocyte- 
like cells closest to the NP.23  The elongated cells of the AF align their cell processes along 
the fibers of each lamellae, functioning to produce the highly organized collagenous 
matrix.23 Considering this, a tissue engineered scaffold that mimics the angle-ply 
architecture of native AF must also provide the correct cues to produce similar cell 
alignment. Additionally, the scaffold must provide adequate support for cell life. To 
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achieve these goals, the FT-AFRP was engineered. The studies herein aim to determine the 
FT-AFRP’s influence on cell alignment and viability. 
 Difficulties in obtaining healthy and autologous AF cells has shifted focus to the 
use of stem cells with hopes of differentiation into relevant cell types. In either case of AF 
cell or stem cell implantation, a fibroblast-like elongated cell type is desirable to mimic 
native AF cells. The studies herein use cells isolated from bovine AF tissue. While this cell 
type may not be viable in clinical applications due to immunogenic complications, it 
provides a meaningful representation of how autologous human AF cells or properly 
differentiated stem cells may act upon implantation into FT-AFRPs. 
 As described previously and shown in Figure 17, the fibrous pericardium used for 
FT-AFRP production is attached to a layer of parietal pericardium. Removing the parietal 
layer results in only fibrous tissue and acts as a means to expose the individual collagen 
fibers. In order to allow interaction between cells and fibers, cells were seeded on the fiber-
exposed side of pericardium. 
4.2 Materials and Methods 
4.2.1 Bovine AF Primary Cell Isolation and Treatment 
 Primary bovine AF cells (bAFCs) between passage 4 and 6 (P4-P6) were used for 
all studies. Cells were previously isolated from fresh bovine caudal IVDs, passaged 2 
times, and frozen in liquid nitrogen. Before each study, cells were thawed and expanded 
between P4 and P6. Cell culture media (CCM) was composed of 88% Dulbecco’s Modified 
Eagles Medium (DMEM), 10% Fetal Bovine Serum (FBS), 1% antibiotic/antimycotic 
(ab/am) solution, and 1% 200mM L-glutamine. 
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4.2.2 Investigation of bAFC Cell Alignment on Decellularized Pericardium 
 Sheets of porcine pericardium were decellularized and crosslinked as previously 
described. Pericardium samples were cut to squares approximately 2 x 2 cm2. To ensure 
cells were seeded on the fiber exposed side of pericardium, samples were analyzed using 
bright field microscopy and a polarizing light filter. Samples were subsequently marked 
with a tissue pen to indicating the fiber exposed side. All samples underwent a sterilization 
procedure including a 2-hour submersion in pH neutral 0.1% peracetic acid and three 
subsequent washed in sterile PBS. Sterile pericardium scaffolds were then neutralized 
overnight in a 50% DMEM and 50% FBS.  
 Samples (n=4/timepoint) were placed in an untreated 12-well plate. bAFCs were 
counted, suspended in CCM, and diluted to a concentration of 1,000,000 cells/mL. 200,000 
cells were seeded dropwise onto each sample of pericardium. Seeded samples were placed 
in an incubator at 37℃ and 5% CO2 for two hours to allow cells to adhere to scaffolds. 
After 2 hours, 2 mL of CCM was added to each well and samples were placed back in the 
incubator. 
 
Figure 34: Overview of cell alignment study of bAFCs on decellularized pericardium. Figure depicting samples 
(n=4/timepoint) after initial cell seeding (left) and with CCM added after a 2-hour adherence period (right). 
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 Samples were cultured to 1, 3, and 6 days. CCM was changed on days 1 and 3. At 
each timepoint, samples (n=4) were removed from CCM, rinsed twice by dipping in 1x 
PBS, placed in a new well plate, and stained with a solution of 10µM Calcein AM and 
2µM Ethidium homdimer-III (EthD-III). Calcein AM permeates through intact cell 
membranes and stains the cytoplasm of viable cells. EthD-III cannot penetrate intact cell 
membranes and therefore stains cytoplasm of non-viable cells after the cell membrane is 
damaged. Samples were left in the staining solution for 30-45 minutes, shielded from light 
at room temperature. Axio Zeiss Vert. A1 camera microscopy with Axio Vision SE64 Rel 
4.9.1 software was used for imaging all samples. First, live and dead cells were imaged 
using fluorescence microscopy. Live cells appeared green under blue fluorescent light. 
Dead cells appeared red under green fluorescent light. Without moving samples, the 
microscope was switched to brightfield microscopy and the polarizing filter was added to 
image the fiber orientation of samples. 
 Viability was assessed by manually counting the number of live and dead cells 
across various samples for each time point. Images taken at 200x total magnification were 
used for all viability counts. Viability was taken as % 𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉 =  𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿 𝐶𝐶𝐿𝐿𝐶𝐶𝐶𝐶𝐶𝐶
𝑇𝑇𝑇𝑇𝑡𝑡𝑇𝑇𝐶𝐶 𝐶𝐶𝐿𝐿𝐶𝐶𝐶𝐶𝐶𝐶
× 100. 
Statistical analysis was performed to compare viability across various timepoint. Graphpad 





Figure 35: Example image of A) counted live cells stained with calcein AM, B)  counted dead cells stained with 
EthD-III, C) calculation of percent viability.141 
 A follow-up study was conducted to investigate the ability of bAFCs to align on 
the non-fibrous side of decellularized pericardium. Pericardium samples (n=3) were 
marked on the non-fibrous side, seeded as previously described, and cultured for three 
days. Samples were imaged and viability counts were made as previously described. 
4.2.3 Investigation of the FT-AFRPs ability to support bAFCs 
Trial 1 
 Decellularized sheets of pericardium (approximately 4x4 cm2) were sterilized as 
previously described. Nine sheets of pericardium were seeded with 800,000 cells at a 
concentration of 1,000,000 cells/mL. Seeded pericardium layers were placed in the 
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incubator for 2 hours to allow cells to adhere. Alginic acid sodium salt powder was 
sterilized using a 12-hour ethylene oxide treatment and subsequently used to create a sterile 
alginate solution. CaCl2 crosslinker solution was sterile filtered prior to use. The 3-D 
printed fabrication base was autoclaved prior use.  
15-layer sterile plugs (n=4/timepoint) were fabricated by stacking sterile 
pericardium layers onto the 3-D printed base. Three seeded layers were incorporated into 
each plug. The 1st, 8th, and 15th layer of each plug was a seeded pericardium layer. Once 
staked, plugs were punched using a 6mm biopsy punch, dipped in sterile alginate, and 
dropped into sterile CaCl2 crosslinker solution for 10 minutes. Plugs were then placed into 
separate wells of a 96 well plate and 250 µL of CCM was added on top of each plug. The 
plugs were placed in the well plate such that walls of the plug fit against the walls of the 
well. This was intended to simulate a reduced nutrient environment by only allowing CCM 
to diffuse through the plug to reach bottommost layers. Samples were placed in an 
incubator at 37℃ and 5% CO2. Sample imaging timepoints were 1, 3, and 6 days. CCM 
was changed every 24 hours.  
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Figure 36: Fabrication of seeded FT-AFRPs for cell viability study. Figures representing A) pericardium layers 
in petri dishes seeded with bAFCs, B) 3 seeded and 12 unseeded layers of pericardium stacked onto the 3D 
printed fabrication base, C) a top down view of the stacked layers with circles and points representing biopsy 
punch locations and needle punctures respectively, D) a seeded FT-AFRP after being punched from stacked 
pericardium and dip coated in alginate, E) culture environment for FT-AFRPs in 96 well plate with arrows 
indicating direction of nutrient transport through pericardium layers. 
At imaging timepoints, FT-AFRPs were removed from the 96 well plate and dipped 
into a sodium citrate chelator solution for 20 seconds. Layers were separated one at a time, 
rinsed twice by dipping in sterile PBS, and placed in separate wells of a 24 well plate. 
Live/dead staining was performed using a Calcein AM and EthD-III solution as described 
in section 4.2.2.  Samples were immersed in staining solution for 30 minutes at room 
temperature shielded from light. Samples were then imaged using fluorescent light to view 
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live and dead cells. Viability was calculated by manually counting the number of live and 
dead cells across various sample images at 200x total magnification.  
Trial 2 
 A similar procedure to trial 1 was used with slight modifications. 800,000 cells 
were seeded onto sheets of pericardium but at an increased suspended density of 1,250,00 
cells/mL of CCM. Enough sheets were seeded to allow for three seeded layers in each FT-
AFRP as well as a control sample for each time point. Once cells were seeded, scaffolds 
were placed in the incubator at 37℃ for 2 hours to allow cell adherence to scaffolds. CCM 
was then added to each sheet of seeded pericardium and cells were cultured overnight to 
allow further interaction between cells and pericardium. After 24 hours of culture, 15-layer 
plugs were fabricated following the procedure from trial 1. Precaution was taken to prevent 
overhandling or shear stresses exerted on seeded layers. Stacked layers were punched with 
a 6mm biopsy punch, dipped in alginate, and dropped in CaCl2 for 10 minutes. 
Seeded FT-AFRPs (n=3/timepoint) were cultured for 1,3, and 6 days in a 12 well 
plate, submerged in CCM. CCM was changed on day 1 and 3. The control sample for each 
timepoint was cultured under the same conditions for 1, 3, and 6 days.  
 
Figure 37: Culture condition comparison between A) trial 1 and B) trial 2 of cell viability study. 
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On day 1 and 3, plugs (n=3) were removed from CCM and rinsed twice by dipping 
in PBS. Whole FT-AFRPS, with alginate coating intact, were submerged in live/dead 
solution for 30 minutes shielded from light. Day 6 samples were stained using the 
procedure from trial 1. That is, FT-AFRP layers were split apart and rinsed in PBS before 
placing into live/dead stain for 30 minutes. The control sample for the corresponding 
timepoint was also rinsed and stained. FT-AFRPs were removed from staining solution and 
layers were split apart. All layers were imaged using florescence microscopy to visualize 
live and dead cells. Viability was calculated as previously described for FT-AFRPs at all 
time points as well as for control samples. Statistical analysis was performed to compare 
viability across various timepoint. Graphpad Prism 7 software was used to perform a one-
way ANOVA with significance denoted as (p<0.05). 
4.3 Results 
4.3.1 Investigation of bAFC Cell Alignment on Decellularized Pericardium 
 BAFCs cultured on the fibrous side of decellularized pericardium began to show 
alignment as early as day 1. The AF cells possessed a primarily elongated cell shape with 
the processes of most cells pointing in the same direction. A lower occurrence of a more 
rounded cell type was evenly spread throughout samples. Regional differences in cell 
alignment, cell density, and cell shape were seen within each sample. Similar trends were 
seen for day 3 samples. Scaffolds seemed to be slightly more crowded and aligned, but still 
showed regions of a mixed cell type including rounded cells. Day 6 showed the most 
substantial alignment and scaffold crowding. A lower occurrence of rounded cells seemed 
to be present on day 6 compared to days 1 and 3. 
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Figure 38: Day 1 samples of decellularized pericardium seeded with bAFCs. Representative images at 100x and 





Figure 39: Day 3 samples of decellularized pericardium seeded with bAFCs. Representative images at 100x and 




Figure 40: Day 6 samples of decellularized pericardium seeded with bAFCs. Representative images at 100x and 





Percent viability for days 1, 3, and 6 were 98.65 ± 1.60%, 90.18 ± 6.26%, and 
86.18 ± 7.25% respectively (Figure 41). No significant differences were noted between 
groups for (p<0.05). The average across samples from all timepoints was 91.57 ± 7.72%. 
 
Figure 41: Average percent viability of bAFCs seeded on decellularized pericardium. 
 Cells seeded on the non-fibrous side of decellularized pericardium showed less 
alignment compared to day 3 samples with cells seeded on the fibrous side of pericardium. 
Additionally, the primary cell shape was rounded. Small regions of partially aligned 
elongated cells were seen throughout samples. Percent viability averaged 91.77 ± 2.76% 




Figure 42: Day 3 samples of decellularized pericardium seeded with bAFCs on the non-fibrous side. 
Representative images at 100x and 200x total magnification of A&C) lack of fiber orientation, B&D) live cells, 
and C&F) dead cells. 
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Figure 43: bAFCs seeded on the non-fibrous side of decellularized pericardium. A) Fiber orientation, B) live 
cells, and C) dead cells in a region showing moderate alignment and elongated cell shape. 
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Figure 44: Average percent viability of day 3 samples seeded with bAFCs on the fibrous (aligned) and non-
fibrous (unaligned) side. 
4.3.2 Investigation of the FT-AFRPs ability to support bAFCs 
 Trial 1 resulted in little to no viable cells across all samples. On day 1, dead cells 
were found on all three seeded layers of various FT-AFRP samples. Viable cells that were 
found were in clusters of 2-10 cells and had a rounded shape. The majority of viable cells 
found were located on the top layers of the FT-AFRPS, closest to the CCM in the 96 well 
plate. While viable cells were seen, there were too few to obtain an accurate estimation of 
average percent viability. These results were confirmed in day 3 samples with even fewer 
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viable cells found. Due to the projected continued lack of viable cells, day 6 samples were 
not imaged. 
 
Figure 45: Trial 1 of FT-AFRPs seeded with bAFCs. Representative images at 100x and 200x total magnification 
of A&C) live cells and B&D) dead cells on single layers of pericardium from FT-AFRPs.  
 Regions found with live cells were inconsistent, normally showing a small cluster 
of 2-4 cells. One region of a top layer of seeded pericardium showed approximately 15 




Figure 46: Small regions of viable cells found on the top layer of FT-AFRPs. Images showing A&C) live cells and 
B&D) dead cells.  
 Trial 2 samples imaged on day 1 showed no cells, live or dead. The day 1 control 
sample of seeded pericardium showed elongated and aligned cells with a viability of 
approximately 99%. Day 3 FT-AFRPs and the corresponding control sample showed 
similar results to Day 1, with a control viability of approximately 97%. No viability data 
was obtained from the day 1 or 3 FT-AFRPs due to the lack of stained cells. Day 6 samples, 
which reverted back to the staining method from trial 1, showed both live and dead cells 
across various layers of FT-AFRP samples. While the samples were not abundantly 
populated with cells compared to the controls, large clusters of both live and dead cells 
were found with primarily rounded cell type. Average viability for all layers of seeded 
pericardium from day 6 FT-AFRPs was 70.37 ± 14.37%. The control sample for day 6 had 
a viability of approximately 92%. 
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Figure 47: Live/Dead control images of bAFCs on sheets of pericardium for FT-AFRP cell viability study. Pairs 
representing A&B) day 1, B&C) day 2, and E&F) day 3. Image pairs show live cells (A,C and E) and dead cells 
(B, D, and F).  
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Figure 48: Day 6 FT-AFRP samples seeded with bAFCs. Representative image pairs of various layers of 




 The use of cells along with mechanically competent scaffolds is an identified 
necessity for AF repair to help maintain ECM structure through maintaining the long-term 
homeostatic balance of matrix turnover in damaged IVDs. To achieve this, the FT-AFRP 
must be cytocompatible with relevant cell types. In addition, an important goal in tissue 
engineering the AF is to allow for potential integration between the repair scaffold and 
surrounding native tissue through infiltration of host cells. The implications of the FT-
AFRP on these items was tested by incorporating bovine AF cells on singular sheets of 
pericardium as well as throughout FT-AFRPs. Human AF cells were not used due to a 
general difficulty in obtaining healthy samples of cells. Additionally, while stem cells may 
be more relevant for clinical use, the aim of this study was to investigate the general 
viability and alignment of a relevant end stage phenotype of native AF. This was achieved 
using readily available bAFCs. The studies herein proved that decellularized pericardium, 
as singular layers, can support bAFC proliferation and provide correct cues to maintain a 
properly elongated cell shape. Despite this, the incorporation of bAFCs into FT-AFRPs 
was only moderately successful as indicated by a lowered cell density compared to control 
samples as well as a round cell shape.  
4.4.1 Investigation of bAFC Cell Alignment on Decellularized Pericardium 
  While previous studies by our group have identified the ability of decellularized 
pericardium to support cell life, no investigations have been done specifically targeted at 
identifying cell alignment and shape after seeding scaffolds. Bovine AF cells began to 
show alignment as early as one day after seeding indicated by staining viable cells with 
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calcein AM. Cells continued to proliferate and further align through 6 days of culture. The 
ability of these cells to remain elongated without incorporating tensile stresses is an 
important finding for future development. While bAFCs did not need tensile stimulus to 
align, it is possible that a tensile stimulus may still be required to achieve proper 
differentiation if stem cells were used. Tensile stimuli could also play a role in ECM 
production and biochemical output of cells. While most cells were elongated, viable 
rounded cells were also observed, especially in regions of lowered overall alignment. This 
points towards the inconsistencies in pericardium tissue but also further supports that the 
cells need cues from collagen fibers to properly align. These rounded cell types may also 
be useful in mimicking different regions of the AF as a higher proportion of rounded cells 
are seen in inner native AF tissue. Percent viability did lower the longer pericardium sheets 
were cultured, but values did not differ significantly. Cells seemed to become much denser 
by day 6. Therefore, the lowered viability at the end timepoint could be due to general 
overcrowding of the scaffolds. 
 The follow up study of seeding bAFCs on the non-fibrous side of pericardium also 
supported the need for collagen fibers to provide cellular cues for alignment and cell shape.  
Cells attached to and were supported by both sides of the pericardium as indicated by day 
3 viability calculations but showed little alignment and a primarily rounded cell shape in 
this follow-up study. This study provided concrete support for always seeding pericardium 
layers on the fibrous side when fabricating FT-AFRPs an AFRPs when aiming for 
elongated and aligned cells. While mimicking the native AF cell population will primarily 
require elongated and aligned cells, layers of pericardium seeded with cells on the non-
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fibrous side could be incorporated into the bottom-most layer of FT-AFRPs to mimic the 
mixed cell morphology seen in the inner AF.  
4.4.2 Investigation of the FT-AFRPs ability to support bAFCs 
While bAFCs seeded on singular sheets of pericardium showed positive outcomes 
towards using the material for AF repair, further investigation was needed to confirm cells 
could live in a multilayered construct sealed with an alginate gel such as the FT-AFRP. 
The initial trial of incorporating bAFCs onto FT-AFRPs was unsuccessful. A large amount 
of mechanical compression and shearing was imparted onto scaffolds through the 
fabrication process. Additionally, fabricated FT-AFRPs were placed into a highly nutrient 
reduced environment. The 96 well plate culture condition was a potentially aggressive 
model of the way nutrients would flow in the native AF. The combination of shear stresses 
and lack of nutrients were most likely the largest contributors to cell death. 
In the second trial, data was not obtained for day 1 and 3 FT-AFRPs samples due 
to a flawed staining procedure. The staining solution may have inadequately penetrated 
through the alginate coating of the FT-AFRP when whole plugs were stained. Additionally, 
if the stain was able to penetrate the alginate, it may not have gotten to cell locations due 
to a seal between stacked pericardium layers. The issue arising from inadequate stain 
penetration was supported by readily visible and highly viable cells seen on control samples 
stained with the same solution. The revert in procedure back to separating pericardium 
layers before staining fixed the issue. Day 6 samples showed an average viability of 70.37 
± 14.37%. While viability levels were not as high as control values, further refinement of 
the fabrication process to reduce negative mechanical stimulus could provide further 
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improvement. Overall, the study showed that bAFCs are moderately supported by FT-
AFRP scaffolds and that the alginate coating does not pose a significant barrier to nutrient 
diffusion for cellular support. While the viability values alone supported moderate success, 
overall cell density and shape give rise to further challenges of incorporating cells in FT-
AFRPs. Cell shape in the FT-AFRP was rounded and total cell counts were much lower 
than control samples. The reduced cell proliferation compared to singular sheets of 
pericardium could be due to some reduced nutrient flow imposed by the alginate and 
adjacent pericardium layers. The layers adjacent to seeded layers may have also posed a 
physical barrier for cell migration. The rounded cell shape is another concern which must 
be induced by the physical environment of adjacent layers touching seeded layers. While 
cells were initially seeded on the fibrous side of the pericardium, they could have been 
receiving cues from the non-fibrous layer that was placed in contact with seeded layer. 
Additionally, cells could have attached to the adjacent layer of pericardium, influencing 
cell shape. The layers of pericardium were pulled apart from one another for staining and 
imaging. This could have also altered cell shape if cells had indeed attach to both the 
pericardium layer that the cells were seeded on as well as the second layer stacked on top 
of it. Further investigation is needed to understand the root cause of the rounded cell shape 
as well as ways to fine tune it. Additionally, a more consistent method of cell incorporation 




CONCLUSIONS AND FUTURE RESEARCH DIRECTIONS 
5.1 Conclusions 
 The FT-AFRP was developed following the identified need for a full thickness AF 
repair material following outer AF closure. Tissue engineering constructs have been widely 
developed in recent years but continually fall short in mimicking the angle-ply structure of 
native AF or in providing adequate mechanical restoration to the IVD. However, we have 
developed a method to repeatably fabricate a full thickness annular plug using sheets of 
decellularized pericardium which possess a highly structured matrix of aligned collagen 
fibers. The AF repair plug possesses compressive properties suitable for the conditions 
within a repaired IVD, especially when further supported by an outer annular closure 
device such as the AFRP. Additionally, it has been demonstrated that the pericardium used 
to fabricate the FT-AFRPs adequately supports AF cell viability and provides cues for cell 
alignment and an elongated cell shape. The FT-AFRP provides the last major piece of a 
repair system including an NP replacement as well as an outer AF closure patch. This repair 
system is intended to repair the IVD following IVDH. Additionally, the repair system could 
provide a much-needed early stage intervention for patients with signs of IVDD. The 
inclusion of the FT-AFRP in our in situ bovine repair model demonstrated partially restored 
spinal kinematic parameters and hinderance of re-herniations. Despite these successes, 




5.2 Future Research directions 
 Future studies should first focus on refining the method to adhere pericardium 
layers together to provide a more robust scaffold for implantation. Additionally, a suturing 
technique needs to be developed to instantly establish a mechanically competent 
connection between the FT-AFRP and surrounding tissue. The focus of this development 
will need to re-establish tensile pre-strain in the AF. Also, further cell studies need to be 
done with MSCs to determine the FT-AFRPs influence on differentiation into relevant cell 
types. This also warrants an investigation of the induced long-term tissue remodeling and 
regeneration on mechanical properties of the scaffold. Lastly, a GAG gel needs to be 
incorporated between FT-AFRP layers to further mimic native AF biochemical content. 
The influence of this gel on cellular and mechanical characteristics of the FT-AFRP will 







CUSTOM MATLAB CODES 
 
Tension Compression Cycle Data Analysis 
 
Read In Data and Clean Up Data 
Cyclic Tension and Compression 
Compression 
Range of Motion 
Slow Ramp 
Output 
%Alex Garon     Ortho-X     7/17/2018 
 





Read In Data and Clean Up Data 
 
raw = load('bFSU-1-UTC.txt'); %read in file 
 
c1 = 1; 
while abs(raw(c1,3)-raw(c1+5,3))<=1 %find where first cycle starts 
    c1=c1+1; 
end 
raw = raw(c1:end,:); %remove everything before the found point 
 
loc = find(raw(:,3)>=mean(raw(length(raw)-100:length(raw),3))+1); %find where slow 
ramp ends 
raw = raw(1:loc(end)+10,:); %remove points after found location 
 
raw(:,1:2) = raw(:,1:2)-raw(1,1:2); %Set zero values for time and discplacemnt 
Cyclic Tension and Compression 
 
loc2 = find(raw(:,3)<=mean(raw(length(raw)-100:length(raw),3))+1); % Find the bottom 
of a cycle, lines 25-27 are accuracy adjustments 
loc2 = loc2(1)+10; 
loc2 = find(min(raw(loc2-10:loc2+10,3))==raw(:,3)); 
loc2 = loc2(1); 
 
points = 10/raw(2,1); %Estimating total data points in single cycle assuming .1 Hz 
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loc35start = round(loc2+(35*points)-round(points));%finding the start of the 35th cycle 
(Max Compression -> Tension -> Max Compression) 
loc35end = round(loc2+(35*points)); 
sine(:,1) = raw(loc35start:loc35end,2); 
sine(:,2) = raw(loc35start:loc35end,3); 
Compression 
 
sixtypC = .6*min(sine(:,2)); % 60% of max compression 
locC = find(sine(:,2)>sixtypC);%find 60% value in unloading compression curve 
locC = locC(end); 
compression = sine(locC+1:end,:); %isolting max to 60% max compression 
cC = polyfit(compression(:,1),compression(:,2),1); 
CStiff = cC(1); 
 
%Tension 
sixtypT = .6*max(sine(:,2)); 
maxT = find(sine(:,2)==max(sine(:,2)),1); 
locT = find(sine(1:maxT,2)<sixtypT); 
locT = locT(end); 
tension = sine(locT+1:maxT,:); 
cT = polyfit(tension(:,1),tension(:,2),1); 
TStiff = cT(1); 
Range of Motion 
 
RoM = abs(max(sine(:,1))-min(sine(:,1))); %Total Range of Motion 
inflectT =find(sine(:,2)>0,1)-1; %Location where tensile loading starts 
inflectC =find(sine(maxT:end,2)<0,1)+maxT-1; %Loacation where compressive loading 
starts 
RoMC = abs(sine(inflectC-1,1)-sine(end,1)); %Compressive RoM 
RoMT = abs(sine(inflectT+1,1)-sine(maxT,1)); %Tensile RoM 
 















locSR = find(abs(raw(:,3)-raw(1,3))<.1); %finding location of slow ramp start 
locSR = locSR(end); 
locSR = find(max(raw(locSR-50:locSR,3))==raw(:,3)); 
LocSR = locSR(end); 
SR = raw(LocSR:end,:); %Isolating SR data points 
figure('color','w') 
SRPF = polyfit(SR(:,2),SR(:,3),1); %fitting the data 




xth = SR(1,2):-.01:SR(end,2); 










fprintf('CS: %.4f\nTS: %.4f\nSlowRamp: %.4f\nRoM: %.4f\nCompressive RoM: 





Compressive RoM: 1.8290 
Tensile RoM: 3.1710 
Published with MATLAB® R2019b 
 
Creep Data Analysis 
 
%Alex Garon     Ortho-X     7/17/2018 
 
%Program for data analysis of .TXT file from bose creep output 
%Open .TXT file and delete all text from the file then re-save 






%%Load In Data 
A = load('bFSU-6-R2.txt'); 
Add Adjustment Values 
 
A(:,4) = A(:,1); %Time 
A(:,5) = A(:,2)-A(1,2); %Adjusted Displacment 
[R, C] = size(A); 
Displacements 
 
mxdis = min(A(:,3)); %Max Force 
av=mean(A(find(abs(mxdis-A(:,3))<1,1):end,3)); 
loc = A(find(abs(av-A(:,3))<1,1),1); 
endloc = 3600+loc; %Find where where sample has been under load for 3600 s 
Step = A(find(abs(av-A(:,3))<1,1),5); %Step Displacement 
Total = A(find(A(:,1)>=endloc,1),5); %Total Discplaement 
Creep = Total - Step; %Creep Displacement 








%title('Bose Creep Test') %Plot Title 
%xlabel('Time [s]') %x axis label 





s = 367.9; 
n = 5088; 
w = 154; 
m = 345597; 
x = A(:,4); 
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